ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note
BGC0000625.1|Thioviridamide_1 # 2 # 193 # 1 # ID=1_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.729	BGC0000625.1|Thioviridamide_1 	2	193	+	Loose	550	24.6386	vgbC	33.33	3003990	protein homolog model	n/a	n/a	streptogramin antibiotic	antibiotic inactivation	streptogramin vgb lyase	ACCCCGTCGGCCGCCCGGCAGCCGTACCGGTCCCACGGGAGACGTTCCGTCCCTCGTGGCCGGACCGGCCGCCGGCTCCGACGGATCGTCACCGCAGCGTCGCGAAACGAACGCCCCGGCATCGCTTTGGTGTCGGGGCGGTCGCGCATCCGGACGGCCGAGGTGTGGTGTCAGTGGCTGCGGATAGGCTGA	TPSAARQPYRSHGRRSVPRGRTGRRLRRIVTAASRNERPGIALVSGRSRIRTAEVWCQWLRIG	MQIAAQEYKTANRESGPYGITARQDRTIWFTEQKGNRIGRLTKDGDMRTFEVPTPDAGVMSILSAHTGDLWFTEYKANKIGRMTMEGTFAEFELPEANSSPYGLAEGPDGAIWFTELSGNRIGRITPAGIITEYDLPCEGSYPSYITAGPDGALWFTENQNNCIGRITVDGEITEYRIPTEQSGPVGITTGADGALWFVQINGNQIGRITTAGEITEFKLPSGNARPHAITAGVSGDLWFTEWGANQIGRITCTGDITEYPIPTPSAEPHGITVDSGGEVWFAEECDQIGRFTIQY	21.28	gnl|BL_ORD_ID|2296|hsp_num:0	2526		
BGC0000625.1|Thioviridamide_2 # 198 # 3509 # 1 # ID=1_2;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=8bp;gc_cont=0.760	BGC0000625.1|Thioviridamide_2 	198	3509	+	Loose	1050	32.3426	lmrC	29.41	3002881	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic; tetracycline antibiotic; oxazolidinone antibiotic; phenicol antibiotic; pleuromutilin antibiotic	antibiotic target protection	ABC-F ATP-binding cassette ribosomal protection protein	ATGACGCGAGCCGAGCAGCCAACGGCCCCCACCCCAGCACCGGACGACGCCCTCGTCGCGGACTCCCGCGAGCGTGCCGTCCGTTCCCTGCTGCGCCGACCGGAGCTGCGGCGCCTGTGGAGCGCCCAGCTCGTGAGCGGTGTCGGCGACACCCTCGCGGTCCTGGTGCTGGTCGTCCTCGCCCTCCAGGCAGCCATCGCGGAGGGCTCCTTCGGCGGTGGATACCGCGGCGTCGCGTTCGCGGTGGCGACCGTCTTCGCGGCCCGCATCCTCGCCACGCTGCTCTTCGGGGCCGTCCTCCTCGGCCCGCTCAGCGCGCTGACCGACAAGGAAGGCCCGCTGGACCGCCGCTGGACCATGGTCGGCGCCGACGGTCTGCGTGCCGTACTGCTGATCATCGCGCCCCTCTGGATCGACTGGACGCCGCAGAACGCGCTGGCGTATCTGCTCGTCACCGCCTTCGTCACCGGAGTCGCCGAGCGCCTGTGGACGGTGTGCCGGGAGAGCGCGGCCCCCGCGCTGCTGCCCGCCCCGCCCCCGGAGGGAGCGACCGTACGGCCGCTGCCGGACCACATGGACGCCCTGCGCCGCCTGGCGCTGCGCACCACGTTCCTGGCGATCCCGCTCGCGGCCGCCGCGCTCGTCGTCGCCGCGCTCTTCAACAACCTGCTCGGGACCGGTGTCGACTGGTTCGACCAGCACCAGGCGGCCCTCGGGTCGTACGTGGCGGCCGGTCTGTTCGCCGCCTCCCTGTCGGTGCTGACCGCCCTGGAGCTGCCCGGCATCCGCACCCCACGCGCGCGGTCCCCGCTGGAGGGCCTGCGCCGCCCGCGCACCGGCGCCGGTGTGGACAAGGGCCGTACGGGCGCCATCCCGCTGCTCGTCCCGGCCTGCGCCGCCGTCGCCGGGGCCATCTCCGCCGCCGTCTCCGTGTGCGTGCTGCACGCCAAGGACCTGGGCGGCGGCCCGGTCCTGTACGGCCTGCTGGTCCTCGCGCTGACCGGCGGCGTCGCCGTCGGCATCCGTACGGCGCCCTCGATGCTGCCCTCGCTCTCGCGCCGCCGGCTGCTGGCCCTGGCGATCGCCTTCACCGGCGTCGCCCTGCTGGCCGCGGGCCTCGTCCCCGACGTCACCACGGTCCTGCTGATCGTCGCGCTGGCCGGCATCGGCGCGGGCGTGGCCGCAAACACCGGGCACACCCTGCTCGATCAGGAGACCGAGGACCACCGCAGGGCGCGCACCACCGAGCACCTGCACGCGGTGGTCCGCGTCTTCATAGCGCTCGGCGTCCTGATCGCGCCCCTGGTCGCGGCCCTCATCGGCCCGCACCGCCTGGAGAACGGCAAATTCGTCTTCGCGCACGGCGGAGCCGCGTTCACCCTGATGCTGGTCGGCGCGCTGCTGCTGCCGGTCGCCGCGCTGGTCCTCGCCAAGGTCGACGACCGCTCCGGCGTCCCGCTGCGGCACGACCTCAGGGACGCGCTGCTCGGCGGCGACGACCCCGTCCAGGCCCCCGCGTCGAACGGTTTCTTCATCGCCCTGGAGGGCGGTGACGGCGCCGGCAAGTCCACCCAGGCCGAAGCACTCGCCGAGTGGATCCGGGCCAAGGGCCACGAGGTCGTCCTCACCCGGGAGCCGGGTGCCACCCCGGTCGGCAAGCGGCTGCGCTCGATCCTGCTGGACGTGTCCTCCGCCGGCCTGTCCCACCGCGCGGAGGCCCTGCTCTACGCCGCCGACCGGGCCGAGCACGTCGACACCGTCGTCCGGCCCGCCCTGGAGCGCGGCGCGATCGTCATCTCGGACCGGTACATCGACTCCTCCGTCGCCTACCAGGGCGCCGGCCGCGATTTGTCCCCGACGGAGATCGCCCGGATCAACCGCTGGGCGACCGACGGGCTCGTCCCCCACCTCACCGTCCTGCTGGACGTCGCGCCGGAGGCCGCCCGCGAGCGGTTCACCGAGGCGCCGGACCGGCTGGAGTCGGAGCCGGCCGAGTTCCACGCGCGCGTGCGGTCCGGTTTCCTCACCCTCGCCGCGTCCGACCCCGGCCGCTACCTGGTCGTGGACGCCGCGCAGGAACCCGAAGCCGTCACCACGGTGATCCGGCACCGGCTCGACACCGTCCTGCCGCTCTCCGAGGCCGAGATCAAGGCCCAGGAGGAGGCGCGCAAGCGGGCCGAGGAAGAGGCCCGCCGCAAGGCCGAGGAAGAGGCCGCCCGCAAGGCCGAGGAGGAGCGCCTGGAGCGCGAGCGCCAGGAGCAGCTCGCCAAGCTGCGCGCCGAGGAGGAGGAGCGCAAGCGCCGCGAACTGGAGGAGGCGCAGCGCCGGGAGGCCGAGCGGCAGGCGGAGGAGGCCCGGCAGCGCGCCGAGGAAGCGCGCCGCCGTGCCGAGGAGGAGCAGCAGCGGCTCCTCGCCGAGGAGAAGGCCCGCGCCGAGGAGGAGGCCCGCCGCAAGGCCGAGGAGGAACGGCGCCGCAAGCAGGCCGAGGAGGAGGCCCGGCTGCACGCCGAGGCCGAGGCCCGGCGCCTGGAGAAGCAGCGCAAGGCCGAGGAGGCTTTGCTGCGCGCCGAGGAGGCCCGCCGCCAGGCGGCCGAGGCCGCCGCCTCGGCCGACGCGGCGGCCCGCCGGCCCGCGGCACCGCAGCCCAAGGCCCCCGGGATGCCCCCGGAGGCGGCGGCGACGGTCCCGACACCGGCCGTGTCCCCGGCCGACCCGCAGAACCAGCGGCGGACCGCCGCACCGGCGCCGGGCGCCGAGGAGACGGTCCCGACACCGGTCGTCTCCCCGCCCACGGACGAGACGACGGTGCTGCGCCCCGTACGCGAGGACCGCCCCGCGGACGCCTCCCACCCCGACTCCGAGGTGACCACCGAGCTGCCGCAGCCGCCGGCGACCCCGGGCGCGGCGGACGACACGGCGGTGCTCCCACCGGTGGCTCCCGGCGCGGCCGACGAGACCGCCGTACTGCCTCCGGTGCCCCCGGGGGCGGCCGACGAGACGGACGTACTCCCGCCCGTGCGGGACCGTGACCCGGCGGACCGGGTGCCGCCCGGCCTGTTCCGGGACGAGCGGGCCGCCTCCGGCCCCGACGGTTCCGAGAGCCGTACCCGCGAGATGCCCCAGCTCGACGCGGACGGCACCCCCCGGCGCCGGCCGCGCCCCGACTGGGCCGAGGAGACCCCGCTGGACGACCTGCCGAGCCTGGCGGACGAACTCCTCGGTTCGTACGACTCCTACGACTCGCACGACGAGCAGGTGCACGGGGACGTCGAGGAGGACAAGGGCCGACGCGGACGGGGCCGCCGGGGCTGA	MTRAEQPTAPTPAPDDALVADSRERAVRSLLRRPELRRLWSAQLVSGVGDTLAVLVLVVLALQAAIAEGSFGGGYRGVAFAVATVFAARILATLLFGAVLLGPLSALTDKEGPLDRRWTMVGADGLRAVLLIIAPLWIDWTPQNALAYLLVTAFVTGVAERLWTVCRESAAPALLPAPPPEGATVRPLPDHMDALRRLALRTTFLAIPLAAAALVVAALFNNLLGTGVDWFDQHQAALGSYVAAGLFAASLSVLTALELPGIRTPRARSPLEGLRRPRTGAGVDKGRTGAIPLLVPACAAVAGAISAAVSVCVLHAKDLGGGPVLYGLLVLALTGGVAVGIRTAPSMLPSLSRRRLLALAIAFTGVALLAAGLVPDVTTVLLIVALAGIGAGVAANTGHTLLDQETEDHRRARTTEHLHAVVRVFIALGVLIAPLVAALIGPHRLENGKFVFAHGGAAFTLMLVGALLLPVAALVLAKVDDRSGVPLRHDLRDALLGGDDPVQAPASNGFFIALEGGDGAGKSTQAEALAEWIRAKGHEVVLTREPGATPVGKRLRSILLDVSSAGLSHRAEALLYAADRAEHVDTVVRPALERGAIVISDRYIDSSVAYQGAGRDLSPTEIARINRWATDGLVPHLTVLLDVAPEAARERFTEAPDRLESEPAEFHARVRSGFLTLAASDPGRYLVVDAAQEPEAVTTVIRHRLDTVLPLSEAEIKAQEEARKRAEEEARRKAEEEAARKAEEERLERERQEQLAKLRAEEEERKRRELEEAQRREAERQAEEARQRAEEARRRAEEEQQRLLAEEKARAEEEARRKAEEERRRKQAEEEARLHAEAEARRLEKQRKAEEALLRAEEARRQAAEAAASADAAARRPAAPQPKAPGMPPEAAATVPTPAVSPADPQNQRRTAAPAPGAEETVPTPVVSPPTDETTVLRPVREDRPADASHPDSEVTTELPQPPATPGAADDTAVLPPVAPGAADETAVLPPVPPGAADETDVLPPVRDRDPADRVPPGLFRDERAASGPDGSESRTREMPQLDADGTPRRRPRPDWAEETPLDDLPSLADELLGSYDSYDSHDEQVHGDVEEDKGRRGRGRRG	MADASIVCTNLSFSWPDETPVFDGLSFALGAGRCGLVGPNGAGKSTLLRLAVGELTPTAGSITAQGHVGYLPQSLPLIDGTVDEALEIASIRAALHAIESGDVDEAHFTTVGDHWDIEERTTIVLDRLGLGDVSLDRPLRSLSGGQVLAIGLAAQLLKRPDVLILDEPTNNLDLAARQRLYQVVEEWKGALLVVSHDRELLDRVDTIAELQASELRLYGGNFTAYTEAVELEQENVQRAVRGAEQELRRHKREAQAAQERAQRRASNAKRNKASSGVPRIHAGALQRQAQESAGRAASVHQDRVSQAKAKLDEASQGMREEARLAITLPQTSVPAGRTVLTCHEANVRYGERTLFTGSGVDLGIRGPERIALLGPNGSGKSTLLKLIAGELEPSSGTVTAPTDRVSYLSQRLDLLDLDASVLDNLRRFAPHLQDGEVRYRLAQFLFRGDRVHRTAGWLSGGERLRATLACVLSTDPAPQLLLLDEPTNNLDLNSAAQLENALNAFQGAFVVVSHDQAFLRAIGVSRWLRLADGTLEEIAEADDAWPHRDK	200.55	gnl|BL_ORD_ID|922|hsp_num:0	974		
BGC0000625.1|Thioviridamide_3 # 3664 # 4869 # 1 # ID=1_3;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.747	BGC0000625.1|Thioviridamide_3 	3664	4869	+	Loose	600	27.7202	CfxA6	40.0	3003097	protein homolog model	n/a	n/a	cephamycin	antibiotic inactivation	CfxA beta-lactamase	ATGACCGTGTGGGACGACCTCGTCGGGCAGGAGAAGGTGAGCGCGGCGCTCGACGCCGCCGCGCGGGACGCCGACGCCCTCGTCACGGCCGCAGCGGCGGACCAACCGCTGCCGGGGTCGTCGAAGATGACGCACGCCTGGCTGTTCACCGGCCCGCCCGGAGCCGGCCGTAACCAGGCGGCGCGGGCCTTCGCCGCCGCCCTGCAGTGCGTCAGCCCCGACCGTGCCCTCGGCGGAACCCCCGGCTGCGGCTTCTGCGACGGCTGCCACACCGCGCTGCTCGGCACCCACGCGGATGTCACCACGGTCGCCGCCGTCGGCTCCGAGGTCCTGGTGAAGGACATGCGGGACACCGTCCGCAAGTCGTTCACCGCCCCGGCGAACGGCCGCTGGCAGACCATCCTCGTCGAGGACGCCGAGCGGCTGAACGAGAAGTCGGCCAACGCCGTCCTCAAAGCGGTGGAGGAGCCCGCGCCCCGCACGGTGTGGCTGCTGTGCGCCCCCTCGATCGAGGACGTCCTGCCGACCATCCGCTCCCGCTGCCGCCACCTGAACCTCAGCACCCCGTCCGTCGCCGCGGTCGCCGACATGCTCGTACGGCGCGACGGCGTCGAACCGGACGTCGCCGCCGAGGCAGCCCGCGCCACCCAGGGGCACGTCGACCGGGCGCGCCGCCTGGCCACGGACCCCGCGGCCCGCGGGCGCCGCGCGGCCGTCCTCAAGCTCCCGCTGCGCCTCGACGAGGTCGGTGCCTGCCTCAAGGCCGCGCAGGAACTCGTCGACGCGGCCGCCGAGGACGCCAAGCAGCTCGCCGAGGAGATGGACGGCAAGGAGGCCGAGGAACTCAAGGCGGCGCTGGGCGCGGCCCAGGGCGGGCGGCTGCCGCGCGGCACCGCGGGGGTGATGAAGGACCTGGAGGACATGCAGAAGCGCCGCAGAACCCGTACGCAGCGCGACAGTCTGGACGTGGCCCTCGGTGATCTCACCGCCTTCTACCGGGACGTGCTCGCCCTCCAGCTCGGCTCGCGCGTCGCCATCGCCAACGCGGACGCGGAGGACGCGCTGGAGCGCCTGGCCCGCTCCGGATCGCCCGAGTCCACCCTGCGCCGCATCGAGGCGATCGCCGCGTGCCGGGACGCCCTGGACCGCAACGTGGCTCCGCTGCTCGCGGTGGAGGCGATGACGATGGCGCTGCGGGCCGGCTGA	MTVWDDLVGQEKVSAALDAAARDADALVTAAAADQPLPGSSKMTHAWLFTGPPGAGRNQAARAFAAALQCVSPDRALGGTPGCGFCDGCHTALLGTHADVTTVAAVGSEVLVKDMRDTVRKSFTAPANGRWQTILVEDAERLNEKSANAVLKAVEEPAPRTVWLLCAPSIEDVLPTIRSRCRHLNLSTPSVAAVADMLVRRDGVEPDVAAEAARATQGHVDRARRLATDPAARGRRAAVLKLPLRLDEVGACLKAAQELVDAAAEDAKQLAEEMDGKEAEELKAALGAAQGGRLPRGTAGVMKDLEDMQKRRRTRTQRDSLDVALGDLTAFYRDVLALQLGSRVAIANADAEDALERLARSGSPESTLRRIEAIAACRDALDRNVAPLLAVEAMTMALRAG	MSNYSVAELRNMKKNRKKQIVVLCIALVCIFILVFSLSHKSATKGSANPPLTDVLTDSISQIVSACPGEIGVAVIINNTDTVSVNNKSIYPMMSVFKVHQALALCNDFDKKGLSLDTLVKINREKLDPKTWSPMMKDYSAPVISLTVRDLLRYTLSQSDNNASNIMFKNMLNTAQTDSFIAKLIPRSSFQIAYTEEEMSADHDKAYSNYTSPLGAAMLMNRLFTESLISNEKQDFIKNALKECKTGIDRIVAPLLDKEGVVIAHKTGSGNVNENGILAAQNDVAYICLPNKVCYTLAVFVKDFKGNESQASQFVAHISAVVYSLLINTALN	121.15	gnl|BL_ORD_ID|248|hsp_num:0	268		
BGC0000625.1|Thioviridamide_4 # 4912 # 6624 # 1 # ID=1_4;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.733	BGC0000625.1|Thioviridamide_4 	4912	6624	+	Loose	500	26.9498	OXA-386	47.37	3001572	protein homolog model	n/a	n/a	cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	GTGTGGCTTCGGGGCGGCGTCCCCCACACGGGCGTACCGGAGCGAACGCCGCCCCCGTCCCCCGAACGAGCCACAAAGCCGACGCACCGCGCTCGCGAGGTCGCACAGCGTTACGCTCGCTTGATGCAGATCAGGCCCACCCCCCGCCGCCCCCGGCCGACGGCCCGAGTCGCCGCCACCCTCCTCGCGGCCGCCGCCCTCCTCGTCTCCGCCTGTTCCCCGAGCAGTTCGACGGTGTCGGCCGGGGCCACGGCGGAGGGGGTGCTGGCGGCGCTGCCGCGTGCGACACCGCCGGCGCTGTCGCCGTACTACGAGCAGAAGCTGCACTGGCGCAGCTGCGGCGCGCCCGGCTTCCAGTGCGCGACGATGAAGGCCCCGCTGGACTATGCGAAGCCCGCCGCGGGTGACGTCCGGCTGGCCGTCGCCCGGAAGAAGGCCACGGGCAAGGGCAAGCCGCTGGGCTCGCTGCTGGTCAACCCGGGCGGTCCGGGCGGCTCGGCGGTCGGCTACCTCCAGCAGTACGCGGGCATCGGCTACCCGGCCGGGGTCCGGGCCCGCTACGACATGGTCGCGGTGGACCCGCGGGGTGTGGCCCGCAGCGAGCCGGTGGAGTGCTTCGACGGCCGCCAGATGGACACGTACACGCAGACGGACACGACCCCCGACGACCGGCGGGAGACGACCGCGCTGGTGACGGCGTACAAGAAGTTCGCGGAGAGCTGCGGGGCGCACTCGGCGCGGCTGCTGCGGCACGTCTCCACGGTCGAGGCCGCCCGGGACATGGACATCCTGCGGGCGGTCCTGGGCGACCGGAAGCTGAACTACGTGGGGGCGTCGTACGGCACGTTCCTCGGGGCGACGTACGCGGGCCTGTACCCGCAGCGGGTGGGCCGCATGGTGCTGGACGGGGCGATGGACCCCTCCCTGGACTCGCGCGAGCTGAACCTGGGCCAGACGGCGGGCTTCGAGACGGCGTTCCAGGCGTTCGCGAAGGACTGCGTACGGCACTCAGGCTGCCCGCTGGGCGGCAGGGGCACCACGCCGGCGCAGGTCGGCGACCACCTCAAGGCGTTCTTCGGCAAGCTGGACGCCCACCCCGTCCCGGCCGGCGACGCGGACGGCCGCAAGCTGGGCGAGTCGCTGGCCACGACGGGCGTGATCGCGGCGATGTACGACGAGGCCGCCTGGGAACAGTTGCGCGAGGCGCTGGCCTCGGCGATGAAAGAGAACGACGGCGCCGGCCTGCTCGCGCTCTCCGACAGCTACTACGAACGTGACGCCGACGGGCACTACACCAACCTGATGATGGCCAACGCCGCCGTGAACTGCCTGGACCTGCCGCCCGCCTTCACCGGTCCCGAGCAGGTGGAGCAGGCCCTGCCCGAGTTCGAGAAGGCGTCCCCCGTCTTCGGCGAGGGGCTGGCCTGGGCCTCGCTGAACTGCGCGTACTGGCCGGTCAGGGCCACGGGGGCGCCGCACCGCATTGAGGCGAACGGCGCGGCCCCGATCGTCGTGGTCGGCACCACCCGGGACCCGGCGACCCCCTACCCGTGGGCCCAGTCCCTGGCCCGCCAGCTCTCCTCGGCCCGCCTCCTCACCTACGTCGGCGACGGCCACACCGCCTACGGCCGCGGCAGCACCTGCATCGACGGAGCGATCAACACATACCTCCTCCACGGCACCCCGCCGGCCCCCCAGAAGCGCTGCTCATAG	MWLRGGVPHTGVPERTPPPSPERATKPTHRAREVAQRYARLMQIRPTPRRPRPTARVAATLLAAAALLVSACSPSSSTVSAGATAEGVLAALPRATPPALSPYYEQKLHWRSCGAPGFQCATMKAPLDYAKPAAGDVRLAVARKKATGKGKPLGSLLVNPGGPGGSAVGYLQQYAGIGYPAGVRARYDMVAVDPRGVARSEPVECFDGRQMDTYTQTDTTPDDRRETTALVTAYKKFAESCGAHSARLLRHVSTVEAARDMDILRAVLGDRKLNYVGASYGTFLGATYAGLYPQRVGRMVLDGAMDPSLDSRELNLGQTAGFETAFQAFAKDCVRHSGCPLGGRGTTPAQVGDHLKAFFGKLDAHPVPAGDADGRKLGESLATTGVIAAMYDEAAWEQLREALASAMKENDGAGLLALSDSYYERDADGHYTNLMMANAAVNCLDLPPAFTGPEQVEQALPEFEKASPVFGEGLAWASLNCAYWPVRATGAPHRIEANGAAPIVVVGTTRDPATPYPWAQSLARQLSSARLLTYVGDGHTAYGRGSTCIDGAINTYLLHGTPPAPQKRCS	MKIKALLLITSAIFISACSPYIVSANPNHSASKSDEKAEKIKNLFNEAHTTGVLVIQQGQTQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGQKRLFPEWEKNMTLGDAMKASAIPVYQDLARRIGLELMSNEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQFAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVNPQVGWLTGWVVQPQGNIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL	208.03	gnl|BL_ORD_ID|489|hsp_num:0	521		
BGC0000625.1|Thioviridamide_5 # 6569 # 6919 # -1 # ID=1_5;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.650	BGC0000625.1|Thioviridamide_5 	6569	6919	-	Loose	530	23.483	OXA-899	36.17	3005093	protein homolog model	n/a	n/a	cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	GTGAGACCAGAATCGAGACCAGGGACGGCCGCACGGCCCGCGCGCAACGTCGTCGCGGCATCCGCTGAACGAGTAAGCCCAGCTCAGACACTGTCTGGGCTGGGCTTAGAAAGAGCCGCCTTCGGGATTCGAACCCGAGACCTACGCATTACGAGTGCGTTGCTCTGGCCATCTGAGCTAAGGCGGCACGCCGACCGCGACTATGGTGCGATCAGCAACGTCGGTAAGTCTACACAGTTTCCGGGGGTGCTCCGTACACGCCCTCGGGGGTGGGGGAAGGCGGGGCTCGGGAGGGCTATGAGCAGCGCTTCTGGGGGGCCGGCGGGGTGCCGTGGAGGAGGTATGTGTTGA	MRPESRPGTAARPARNVVAASAERVSPAQTLSGLGLERAAFGIRTRDLRITSALLWPSELRRHADRDYGAISNVGKSTQFPGVLRTRPRGWGKAGLGRAMSSASGGPAGCRGGGMC	MMKRRHAATGALLAALATFAHAEHPICTIVADGATGKAVLQEGRCDERVTPASTFKLALAVMGFDHGFLKDEHTPVEHFRHGDPDWGGEAWHQPIDPALWLKYSVVWYSQRITHAMGAQTFQAYVRKLGYGNMDVSGDPGKNNGMDRSWITSSLKISPEEQVGFMRRIVNRQLPVSARTYEMVDRTVQTWQVPGGWSVHGKTGTAGPAPGNTSPDGTWDQAHAYGWFVGWARKGDKTYVFANLIQDDKVEPTSGGIRSRDALLARLPEVLAFAGQ	42.18	gnl|BL_ORD_ID|2870|hsp_num:0	3826		
BGC0000625.1|Thioviridamide_6 # 7449 # 7676 # 1 # ID=1_6;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=9bp;gc_cont=0.662	BGC0000625.1|Thioviridamide_6 	7449	7676	+	Loose	875	25.0238	mdtP	55.56	3003550	protein homolog model	n/a	n/a	nucleoside antibiotic; acridine dye	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGACGGAGAAGACTCAAATCACCGACGTTCAGGCGTTCGAGGACCTCGTGGCCAAGGTGCAGGAGATGGACGGCCCCGCGCAGGCGAGCTCCACCGTCGCGGCCCTTGCCGGTCTGGACGCGGCCGAGCTGCAGAACTTCCTCGAGGAGAAGTCCGGCATCTCCCCGGATGAGGAGGCCCAGGGCAGCGTCATGGCCGCCGCTGCGTCGATCGCTCTTCACTGCTGA	MTEKTQITDVQAFEDLVAKVQEMDGPAQASSTVAALAGLDAAELQNFLEEKSGISPDEEAQGSVMAAAASIALHC	MINRQLSRLLLCSILGSTTLISGCALVRKDSAPHQQLKPEQIKLADDIHLASSGWPQAQWWKQLNDPQLDALIQRTLSGSHTLAEAKLREEKAQSQADLLDAGSQLQVAALGMLNRQRVSANGFLSPYSMDAPALGMDGPYYTEATVGLFAGLDLDLWGVHRSAVAAAIGAHNAALAETAAVELSLATGVAQLYYSMQASYQMLDLLEQTHDVIDYAVKAHQSKVAHGLEAQVPFHGARAQILAVDKQIVAVKGQITETRESLRALIGAGASDMPEIRPVALPQVQTGIPATLSYELLARRPDLQAMRWYVQASLDQVDSARALFYPSFDIKAFFGLDSIHLHTLFKKTSRQFNFIPGLKLPLFDGGRLNANLEGTRAASNMMIERYNQSVLNAVRDVAVNGTRLQTLNDEREMQAERVEATRFTQRAAEAAYQRGLTSRLQATEARLPVLAEEMSLLMLDSRRVIQSIQLMKSLGGGYQAGPVVEKK	15.37	gnl|BL_ORD_ID|36|hsp_num:0	45		
BGC0000625.1|Thioviridamide_7 # 7736 # 8065 # 1 # ID=1_7;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.624	BGC0000625.1|Thioviridamide_7 	7736	8065	+	Loose	920	26.5646	OpmD	46.67	3000809	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; tetracycline antibiotic; acridine dye	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GTGCTGCCGCGGTGCGGTGCTCCGCACGTCCAGCGGTCCCGCTGCGTTTCTGACCATGACGTGTCCCGATTCGAAGGCAGGAACTTTGACGAGACCACCCGGGATGCCGAACCCGGGATTCGGAGCCCGAGGGCAGCCCTTGACGCGATATGGGTCGACGCCTTGCCGGTCAACCACTGGCCGAATCCATACAGTCCAGCTCCCTCTTACCGATTTTCATCCGTGATCTGCTGGCAACAATCCAGCTGCCTTGATACGGTCACGACGGTTGGCACACAGAGCTCGCGCTGCAACTGCAGCCCGGTTCGGACTCGGGGGAGATGCCGCTAA	MLPRCGAPHVQRSRCVSDHDVSRFEGRNFDETTRDAEPGIRSPRAALDAIWVDALPVNHWPNPYSPAPSYRFSSVICWQQSSCLDTVTTVGTQSSRCNCSPVRTRGRCR	MKRSYPNLSRLALALAVGTGLAACSVGPDYQRPQSPPPRVASEHLGEFSGERREAPWWSFFDDPQLVRLVDQALARNHDIREARANLRSARALFDDRWLDQLPQVTSQAGYSRSIEQQLDYDGEPRRRLAESYRAGFDAQWEIDLFGRLGRLSDAALARAEAADADLRLVRLSIAADTARAYFEIQGYQRRLDVARAQVRSWRDTLELTRSSLQLGSGLPEDVENAQANLLRSEAAIPPLTTALESARYRLDVLRGEAPGSGAPILDGGAAAPLAKNLPLGDVDRLILQRPDVVSAERQLAASTEDVGAATAELYPRLDLGGFIGFFALRSGDLGSASRAFELAPSVSWPAFRLGNVRARLRAVEAQSDAALARYQRSLLLAQEDVGNALNQLAEHQRRLVALFQSATHGANALEIANERYRAGAGSYLAVLENQRALYQIREELAQAETASFVNVIALYKALGWGSGDLAPGAGQLAAGETAGANR	22.38	gnl|BL_ORD_ID|410|hsp_num:0	442		
BGC0000625.1|Thioviridamide_8 # 8172 # 8402 # -1 # ID=1_8;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.636	BGC0000625.1|Thioviridamide_8 	8172	8402	-	Loose	500	21.9422	APH(3')-IIc	26.67	3002646	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	APH(3')	GTGAATGAGCTGATCCCTGGTAAGGGACTGCCCAAGGCAACTCGCCAGCATTGCGAGGACTGTTGCCTGTCGAGGGGTCATTTCTATCTGCCGACCCTCGGCATCCAGTGTGAGCACAGACCCCAGGAGATAGACGCGGACCGGGGGCAGGACACTCGGCCCGCCAGTGGCCCCCACGATCCCGTCCAGGGAGACGGAGCGTTTCGCGATCACATCGGGATCCGGCCGTGA	MNELIPGKGLPKATRQHCEDCCLSRGHFYLPTLGIQCEHRPQEIDADRGQDTRPASGPHDPVQGDGAFRDHIGIRP	MEASNPFTDGLRLPRAWQEALADAHIERQSIGVSRADVARVHRPGQTDAFLKSEVIDAFSELGDEIARLRWLQAQGQSAPTVIATTEEGGRRWLLMSALPGRDLASSPELAPRRVAELLADALRGLHAVPVANCPFDQQLASRLQAAQARVEAGLVDADDFDDERLGQSPQQVFAELRATRPAHEDLVVSQGDACLPNLTVTDGRFTGFIDCGRLGVADRYQDLALAARSLVHNFGESRCVAALFQRYGAVPDERRLAFYRLLDEFF	28.46	gnl|BL_ORD_ID|961|hsp_num:0	1018		
BGC0000625.1|Thioviridamide_9 # 8576 # 8884 # -1 # ID=1_9;partial=00;start_type=GTG;rbs_motif=AGG;rbs_spacer=9bp;gc_cont=0.647	BGC0000625.1|Thioviridamide_9 	8576	8884	-	Loose	300	25.0238	AAC(2')-IIa	22.95	3004628	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	AAC(2')	GTGCGGCCACTGTTGTGCAGGCACGCCATCAGTCGCGCGTGGAGTCCCTGGTGTCGGGGAAAGCGTGACAGGCTGTCCCGGATCCGCTCGATGACAATCGCGGAACGCCCACAACGAATGTTCACGTCGATCCACTCCGTCAGTGTTTCGATATGCCGCTCGACGGCCTTCAGACGGAATTCATCGGCGAACGGCGCCCGAATGTCGAGCACGGGATCGTCCCGCCACAGGTCGATCGCGCGACGAAGGGCTTCGATTGCCGCTTCATCCCTGCCGGCCGACCGCGCGTCCGCGGCGATCACCCGGTAG	MRPLLCRHAISRAWSPWCRGKRDRLSRIRSMTIAERPQRMFTSIHSVSVSICRSTAFRRNSSANGARMSSTGSSRHRSIARRRASIAASSLPADRASAAITR	MKDRSHDDSMAEVCRNTSENHWLKTDYRTLFRLCPDGRIERENDPDCSPGPRFWLAGCSEGNVFGVRADVPDDIALKLEELASVEPPFTPPAIPKHLERYLSLLGSDGPVTHDLGLIYELPHAQQYPSKARLIGSGSEEGESLMQSWAEDRVPEALFELGFREVADFWTPWCAAVVDGEVASIAFAARLADAGAELGLVTAKAFRGQGFAAAATAGWSRLSALRSRTLFYSTDRDNISSQRVAARLGLRLRGASLRISRA	39.23	gnl|BL_ORD_ID|2267|hsp_num:0	3327		
BGC0000625.1|Thioviridamide_10 # 9262 # 10398 # 1 # ID=1_10;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.711	BGC0000625.1|Thioviridamide_10 	9262	10398	+	Loose	450	33.4982	APH(3'')-Ic	39.34	3002640	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	APH(3'')	ATGGTGAGCACCCGACGCGATGTCCTTCCCGACGCGATGTCGCACCGGCCCCGGTACTCGGTGGAACACCTGCTGCGGCGGCGCATGCACGGCATGGTCCTGCCTGGCTTCGACCGGATCGCAGGGCCGCCCGCACCGCGCGTGACGACTTACATCCACGAGGCGGCCGGTCTCGCCGTCGCCGGCCTGGGCGGCTCCCACGGCTCGTCCGTCATCTCCTGCACGCCGTGCGTGAGCCGCGGCGCCTCGGCGATCGCCGAGACCGACAGCGGTGCGCGCCTGTTCGTCAAGGCGCTGGGGCCCGGAGGGTTCGGCTACGAGAACGAAGCGGTCGTTCTCGGCCTGCTCGGGGACGCCCGGAAGTCCGGAATCCGGGTTCCGGCACCGGAGTTGCTGTTCTGGGATCCGGTCAGGCACGTGCTCGCCACGACGGAGGTGGGCCACTCGGCGTCCCTTGACGTGGTGTTGCGCACCGCGGACGCCCGAGCCGCGGCAACGGCGTCGACCCTGGTGGGACGCGCACTGGCGACGGTGCACGCGGCGCGGGTCGATGTCGGGCCACTGGCGGCGGAGGGCAGGGTCCATCCGTTTCCGCTCGACGACCTGGCGGACCTGACGCCGAGTGAGCTCAGCAGCGGGGTCGGTGTCGACTTCGACGAGTTCGTCGCATGTGTCCAGTCGGTCTCGGCGGAACTGGGGCGACTCAGGGAAGAGCGGTTCGATCCCGTCCTCGTGCACGGGGACCTGCGGGCACCGAATGTCCTGGTCGGACAGAGCCGCGACCCGGCGGAGGACGGCGCGGTCTTCGTGGACTGGGAGCTCGCATGCGTGGGTGACGTGGCCGCCGACGTCGGCACGGTCCTGGCCGAGGCCCTTGCCACGGACCTCGCGGTGCACGGCGACATCCGTACCGCCGGCCTCTGGAACAGGATCTTCCTCGACTCCTACCAGGGGCGGTCGCCCATGGACGAGGAGTCGGTGCTCCGCTCCGTCCGGTACTGCGGCACGCAGTTGATCCGCGGAACCCTCAGCAGGCTGGAGCACCAGGGGACCCTCGGACGGGTGGGACGGCTGCAACTCATCCTCGGGTCGGCGATCCTGCGCGACCCGGCGCGGTCGAAGGGGGTCGCGTGGTGA	MVSTRRDVLPDAMSHRPRYSVEHLLRRRMHGMVLPGFDRIAGPPAPRVTTYIHEAAGLAVAGLGGSHGSSVISCTPCVSRGASAIAETDSGARLFVKALGPGGFGYENEAVVLGLLGDARKSGIRVPAPELLFWDPVRHVLATTEVGHSASLDVVLRTADARAAATASTLVGRALATVHAARVDVGPLAAEGRVHPFPLDDLADLTPSELSSGVGVDFDEFVACVQSVSAELGRLREERFDPVLVHGDLRAPNVLVGQSRDPAEDGAVFVDWELACVGDVAADVGTVLAEALATDLAVHGDIRTAGLWNRIFLDSYQGRSPMDEESVLRSVRYCGTQLIRGTLSRLEHQGTLGRVGRLQLILGSAILRDPARSKGVAW	MTEWLPVTRGESGAGVFRNSDGSSYAKVVDAAAVADLAAERDRVSWAHRHGVPGPAVIDWRVTEDGGACLITSTVRGVAADRLSESALRAAWPAIVEAVRTLHALPADGCPYRRDLDDMLARARAVVGAGAVNPEFLSDEDREVPAEALLDRVEREADLRRREEAADWVVCHGDLCLPNILVDPDRHTVEGFIDLGRLGLADRHADLALLLANTADTVPGFAEEATAGLAAGYPAQVDPERLRFYLALDPLTWG	148.82	gnl|BL_ORD_ID|1935|hsp_num:0	2052		
BGC0000625.1|Thioviridamide_11 # 10392 # 11381 # 1 # ID=1_11;partial=00;start_type=GTG;rbs_motif=AGG;rbs_spacer=7bp;gc_cont=0.699	BGC0000625.1|Thioviridamide_11 	10392	11381	+	Loose	750	28.1054	Yrc-1	27.03	3005035	protein homolog model	n/a	n/a	cephalosporin; penam	antibiotic inactivation	YRC Beta-lactamase	GTGGTGACGGACGCGGCACGCGACGCCTTCCGCGACCGGTTACGCCTCATCTACAACGAGGTCCGGATCGACGACGGGACCATCGTCCACTCCAGGCTCGGCCGGCTGCGTGAATCGCCCGACCTGGAGACGAAGGGCGCACCTCTGCTCAGCCACCTCTGGCGCCTGATCTACCTCTGCTACCACGCCGGCGATGAACGGGCGTCCAGGTTGCTGGTCGACGGAAGCAGGGCGACGACCTCGATCCAGGCCTGGGAGGAGCCGGCGGCGGTGACCAGGATGGAGGCGGCCCATGCCAGCAGGTGGACCCTGTCGCGGGGCTGGACGGTCGTCGACCGCGGCGCACTGATCCGCGCCGCCCGCTCAGGCGTCCAGCTGTCGTGCCGCCCCGACGAGGTCGAAGAGGCCGATGGTGACGGGCAGATCGCACTGCGCATGCCCGCGACCCAGCGCTACACGTTGTCCGGCTGGCTGGTGCTGCACGGCGAACTCGGCAGCGGTCGGCCCGACCACGTCTTCGTCAGGCACTATCTGTCGCTCCACGACGTGGGCAGCGCCGTCCGCGCCATCCACGCCCTGTCGGCCAAGCTGAACCAGGCGCGGGTGCGCTACCACATCAAGGTCGCCAACAACGCCGTCAGCCTGCGCAGGAGGGACGCCTTCATCATCTACTCGGAGGAGCACAGCGCACCTCTGGTGGAGCCGATCGTGTGCGATGCCGTGGAGAGCGGCCTGGTGGACGCGTCGTACACGATGCCGCTGTTCGCCGAGCAGGTCGCGCCCGGTTGGTCGACGGCCGTGGAGTCACGGCATCAGGACCCCAGCCTGTCCTACGGTCAGGCGTGCGCACGGGCCACGAGCCTCGGGGTGATCGAGGCGTGGGAGCGGGGCGCCCGGACGTTCGCAGACTGGTACGCGGCCGTGAGCGAACAGTTCGAAGCGTCGGGGATCGGCCCGCTGCGGTCGCACCGTCCCGGAGGCGCGCCGTGA	MVTDAARDAFRDRLRLIYNEVRIDDGTIVHSRLGRLRESPDLETKGAPLLSHLWRLIYLCYHAGDERASRLLVDGSRATTSIQAWEEPAAVTRMEAAHASRWTLSRGWTVVDRGALIRAARSGVQLSCRPDEVEEADGDGQIALRMPATQRYTLSGWLVLHGELGSGRPDHVFVRHYLSLHDVGSAVRAIHALSAKLNQARVRYHIKVANNAVSLRRRDAFIIYSEEHSAPLVEPIVCDAVESGLVDASYTMPLFAEQVAPGWSTAVESRHQDPSLSYGQACARATSLGVIEAWERGARTFADWYAAVSEQFEASGIGPLRSHRPGGAP	MMHKTLSCALLLVASGSTFATPQTEKKLSGIVDNVVIPLMKEQAIPGMAVAVIYQGQPYYFTWGMADVAGKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPVSKYWPALSGKQWEGISLLNLATYTAGGLPLQVPDNITDETSLQNYYETWQPQWAPGTKRFYSNASIGMFGKLAVKPSGMSFEQAMNKRVFQPLNLTHTWIHVPEREEKHYAWGYRDGKAVHVSPGMLDAEAYGVKSSIKDMASWVRANMTPSEVKDASLQKGILLAQSRYLQVGDMYQGLGWEMLNWPMKATIAVGGSDNKVALAPLSAVEINPPAPALNSSWVHKTGSTGGFGSYVAFIPEKNLGIVMLANKSYPNPARVEAAYRILEALSVE	85.90	gnl|BL_ORD_ID|2827|hsp_num:0	3779		
BGC0000625.1|Thioviridamide_12 # 11228 # 12508 # -1 # ID=1_12;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.725	BGC0000625.1|Thioviridamide_12 	11228	12508	-	Loose	700	25.7942	EreA2	38.46	3002826	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic inactivation	macrolide esterase	GTGAGCACGCTGCCGTTGACGAACGGCCGGAGACTGTTGGTGGTGACGAACTGCTGGGCGGACGGCGTGAGGGCCACGTGCAGTCGGCCCACTCCGGCGGACGAGAGCCACGCCGCCATGTGGGGCCCGGCCACGCTGGAGACGGAGCCGGAGAGGCACATGGTCAGGGTCAATTGGCCAAGGCCCTCGGCCGCGGCGTCGTGCTCAGCCATCGACGGCTCCCTTCACGGAGGGCAGAACCCCCTGCACACGTTTGGCGAGTCGGTAGGTGGAGGCCTCGTCGGCGCGGAACACAGCGGACAACGCGAGGTGGTTCGCGACGCGCTCCACCACCCAGCCCATGACCTCGTCGCCGCCGGGTGCGTCGGCCGGCTCCGGGTGCGCGGCGCGGTACGCGTCGGTCAGGGCGCCGATCGCCTCCCGCAGCCGGCCCGCTTGCTCCTCGGACGCGATCGCGATCGCCTCGGCGTAGTCACCGATCAGGCACCCGAGATCGGCGACGGGATTGCCGATGCCGGCTTCCTCCCAGCCGAGGACCGTGCACGGTTCCCCCGGCACGATGTCACCGGCACCCGGCCGGCCGTGCACGAGCGAACTCCGCCTGGTCCAGGAGGCTGGTTCCACCGACAGCCCGGCGGACAGGCCGGCCCGAATGACGTCGGCGTGCCGCGCATACGCGTCGCGGTCCCCCCACTGGTGCGCCCACGGAGGCCCCGGCAGCCCGGGAACGTCCTCGATCCCGTCGCGTACCTGGTGCAGGCGGCCCAGCGCCCGGCCCAGTCGCGTCGACATCGCCGTGAGCGTCGGCATCCCGGGCATCTCGTTTCCGAACAGGATGTCGAACAGGAGCCCGGATCTGGGAATGCCGCCCCACAGGGACAGGTCGAAGCTCCGCGAGGGCAGCCGGACGTCCACCCCCAGCGGGGGAAGGGTCCGCGCGAGACGGTCGATGCCGGCGCGCGAGGCGGCCCGCGGCGCGGACGTACGCAGATGCATCCACAGGTACTCCGCCGGCTCCCTGCTGAGGTCTCTCAGACAGGCCCTGAAGCCGTCGGCCCCGGGCAGGGTGCGCACCACGTACGTCTGGTCCCGGTGCCACTCGCGGGTCGTGGACTCCGGTACGGCCGTCACGGCGCGCCTCCGGGACGGTGCGACCGCAGCGGGCCGATCCCCGACGCTTCGAACTGTTCGCTCACGGCCGCGTACCAGTCTGCGAACGTCCGGGCGCCCCGCTCCCACGCCTCGATCACCCCGAGGCTCGTGGCCCGTGCGCACGCCTGA	MSTLPLTNGRRLLVVTNCWADGVRATCSRPTPADESHAAMWGPATLETEPERHMVRVNWPRPSAAASCSAIDGSLHGGQNPLHTFGESVGGGLVGAEHSGQREVVRDALHHPAHDLVAAGCVGRLRVRGAVRVGQGADRLPQPARLLLGRDRDRLGVVTDQAPEIGDGIADAGFLPAEDRARFPRHDVTGTRPAVHERTPPGPGGWFHRQPGGQAGPNDVGVPRIRVAVPPLVRPRRPRQPGNVLDPVAYLVQAAQRPAQSRRHRRERRHPGHLVSEQDVEQEPGSGNAAPQGQVEAPRGQPDVHPQRGKGPRETVDAGARGGPRRGRTQMHPQVLRRLPAEVSQTGPEAVGPGQGAHHVRLVPVPLAGRGLRYGRHGAPPGRCDRSGPIPDASNCSLTAAYQSANVRAPRSHASITPRLVARAHA	MTWRTTRTLLQPQKLEFNEFEILNPVVEGARIVGIGEGAHFVAEFSLARASLIRYFVERHDFNAIGLECGAIQASRLSEWLNSTAGAHELERFSDTLTFSLYGSVLIWVKSYLRESGRKLQLVGIDLPNTLNPRDDLAQLAEIIQVIDHLMKPHVDALTQLLTSIDGQSAVISSAKWGELETAQQEKAISGVTRLKLRLASLAPVLKNHVNSDFFRKASDRIESIEYTLETLRVMKAFFDGTSLEGDTSVRDSYMAGVVDGMVRANPDVRIILLAHNNHLQKTPVSFSGELTAVPMGQHLAEREEGDYRAIAFTHLGLTVPEMHFPSPDSPLGFSVVTTPADAIREDSVEQYVIDACGKEDSCLTLTDDPMEAKRMRSQSASVETNLSEAFDAIVCVPSAGKDSLVAL	104.41	gnl|BL_ORD_ID|1429|hsp_num:0	1518		
BGC0000625.1|Thioviridamide_13 # 12579 # 12890 # 1 # ID=1_13;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.670	BGC0000625.1|Thioviridamide_13 	12579	12890	+	Loose	400	22.3274	QnrB37	45.83	3002752	protein homolog model	n/a	n/a	fluoroquinolone antibiotic	antibiotic target protection	quinolone resistance protein (qnr)	GTGGCCCCGGCGACCGCTGCCACGCTGGGAAAACTGGCGAACGGCATCTGCGACAACATCGTGACGCAGATCGTGATGGCCGCCGAATGCCCGGTGATCCTGGCACCGGTCATGAACCCCGCCATGCTCGCCAAGCCCGCCGTCCGCAGGAATCTCGACGCTCTGAGGGCCGAGGGCTTCGTCGTCGCCGAGCCCGGCCAGGGCGTGAACGCGACGAACGGCCGCTGGGAAGCCGGAAGCATGGCCGATTTCCGTTCAGTGTTCGCCGTGGCTCTGAAGTCCGCGGCGGAAAGGAAGAGCGCGAGTGACTGA	MAPATAATLGKLANGICDNIVTQIVMAAECPVILAPVMNPAMLAKPAVRRNLDALRAEGFVVAEPGQGVNATNGRWEAGSMADFRSVFAVALKSAAERKSASD	MTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAILKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSSFDWRAANVTHCDLTNSELGDLDVRGVDLQGVKLDSYQASLILERLGIAVIG	48.13	gnl|BL_ORD_ID|839|hsp_num:0	891		
BGC0000625.1|Thioviridamide_14 # 12883 # 14106 # 1 # ID=1_14;partial=00;start_type=GTG;rbs_motif=AGG;rbs_spacer=10bp;gc_cont=0.703	BGC0000625.1|Thioviridamide_14 	12883	14106	+	Loose	300	30.0314	Erm(37)	51.61	3000392	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic	antibiotic target alteration	Erm 23S ribosomal RNA methyltransferase	GTGACTGAGAGCCTCAACCCCGACACGGTCATGTACCGGCGCCCCGACGTCCTGCTGGAGATCGACACGAGCAACAACTGCAAGGTGCATGTCGACGGCCGGACTCTCTCCTTCGGGCACGCCGCCGTCGGTCTGGTCGACGTCCTGCACCGGCCCCTGACCGTCTCCGAGGCGGTGCGGCGCGTGCGCTCGCGCACGGGAGGGCAACTGGACACCAGGGACGTGATGACCGATCTGGTCGGACTCGTCCACGCCGGGGTCCTGGACACCCGGCCGCGACTCGGGTTCAGCCCGCGGCCATGGCCGGCCGGCGGGTACGACTCCGCCTACGTGCACCTGCGGATACTCAACGACCGGCGTCGCAAGGGCGCTTTCGTCGCCGCGGTCCGCGAGACGGTCCGGCCGGGAGACGTCGTGCTCGACCTCGGGTCGGGGTCCGGCATCCTCGCCGTAGCCGCCGCTCAGGCCGGTGCCAGGAAGGTCTACGCCGTCGAACCTTCGGGAATGATCGGCCTGTCCGAAGCCGTCGCGGAGGCGAACGGCGTGGGCGATCGCATCGAGTTCATCCGAGACTGGTCGACGCGCATCGAACTTCCCGAGAAGGCGAGCGTCCTCACCACGGATCTGGTGGGCAACGAGCCGCTGGACATGAAGATCTGGGAGACGCTCACCGACGCGCGTCAGCGGCATCTGCGCGACGACGCCCGCATGGTTCCCGCTTCGTTCAGGAGCACAGCACGGTTCTACCGCGTCCCCGGCTCCTACCTGTCGGCCCACCGTGGCGCGCCGGCGGACGTGGCCACCTGGAACGACTGGTACGGGATCGACTTCTCACCGCTCGTCGACCAGGACGACCGGGCATGGATCGGAACGTACGAGCGGCCGGAAGTCATCCGTGACTGGCCGACCGCGTCGGACGAGGTCGCGGTGTACGAGTGCGACCTCGCATCCGACGTCAAGCCGTTCGAGGTCGTCACGGCGCCGGTGGACGTCGAGGCGGGCGCCAACGCCGTCGTTCTCTCCTACCGGGCCCGGCTCGGCCCGGGCACGGAGTTCGACGCCGATCCGCGCAAGGGCGGCGCCGACAGCCACTGGTACACGGCCGTGTGGCTGGCGGGCCGGGCAGCCGGACCCGTCGGACCCCGGGCGCGGGTCGAGTACAGGTACCGGGGCGACGGTTCGAGCGGGCTCCACGTCCGCCGCGTGGGGGGAGAGGCACAGTGA	MTESLNPDTVMYRRPDVLLEIDTSNNCKVHVDGRTLSFGHAAVGLVDVLHRPLTVSEAVRRVRSRTGGQLDTRDVMTDLVGLVHAGVLDTRPRLGFSPRPWPAGGYDSAYVHLRILNDRRRKGAFVAAVRETVRPGDVVLDLGSGSGILAVAAAQAGARKVYAVEPSGMIGLSEAVAEANGVGDRIEFIRDWSTRIELPEKASVLTTDLVGNEPLDMKIWETLTDARQRHLRDDARMVPASFRSTARFYRVPGSYLSAHRGAPADVATWNDWYGIDFSPLVDQDDRAWIGTYERPEVIRDWPTASDEVAVYECDLASDVKPFEVVTAPVDVEAGANAVVLSYRARLGPGTEFDADPRKGGADSHWYTAVWLAGRAAGPVGPRARVEYRYRGDGSSGLHVRRVGGEAQ	MSALGRSRRAWGWHRLHDEWAARVVSAAAVRPGELVFDIGAGEGALTAHLVRAGARVVAVELHPRRVGVLRERFPGITVVHADAASIRLPGRPFRVVANPPYGISSRLLRTLLAPNSGLVAADLVLQRALVCKFASRNARRFTLTVGLMLPRRAFLPPPHVDSAVLVVRRRKCGDWQGR	227.37	gnl|BL_ORD_ID|434|hsp_num:0	468		
BGC0000625.1|Thioviridamide_15 # 14103 # 15461 # 1 # ID=1_15;partial=00;start_type=GTG;rbs_motif=AGG;rbs_spacer=4bp;gc_cont=0.675	BGC0000625.1|Thioviridamide_15 	14103	15461	+	Loose	250	28.8758	arr-7	34.15	3002852	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin ADP-ribosyltransferase (Arr)	GTGAAGCTGCGGAACTCGGTACCGAAGGTCGCCGGTGGCGGTCCTCACCGCGAAAGGACCACGGAGGAGACCTGGCGCACGATCCAGCCGTACCTGCGGCGCGTCGGTGTGACGCGGGTGGCCGACATCACCGGGCTCGACCGGATCGGGATCCCCGTCTACAACGCGATCGTTCCCAAGTCGAGTGACCTGATATCCGTGTACAACGGCAAGGGGGCGTCCCACCTGGACGCCAAGACGTCAGCCGTCATGGAGGCGGTGGAGCGATTCGCCGCGTGGCAGCCTCGGACACCGGATGTCGTCGGCTCGGTGGACGACCTCCGCCGCGACGGCATCCGCGTGGTGCATCCGGACTCGATCAACATCGAGCGCTTCAAGCAGTACCGCGACCACTTCCCGATCTCATGGGTCATGGGCACCGAACTGATCAGCGGTGAGGACATCGCCGTACCGCAGTACCTGGCCGGCTACTACCAGTCCTTCCACGAGACACCGCCCTTCCCGATCTGCACCACCAACGGGATCGCGTCGGGGAACTCGGTCGAGGAGGCCACCTGTCACGCGCTGTGCGAGTTGATCGAACGCGACGACTGGACCATGGCGGAGGTGATCAGCAACCGCCTCAGCCGCGCGGTGACCAAGGGCACGGTCGCGCCGGGCATCCCGGAGACCGTCGAGCAGTGGTTCATGGAACGCAACAGGTCCATCGACCAGGAGACGCTGCCGGCCCCGCACCGCCGGCTCATCGAGCGGTACCGGGCCGCGAACCTGTCGGTGGAACTCAAGAGCATCATGTCGCACAACGGGATCCCGAGCTTCCTGTGCGTCGTCTCGGAAGACCTGGGGCCCACCTTCTCCAGGAGCCACCAGGGCCTCGGCACGCACCCCGACCGTGACGTGGCCGCGCTCCGAGCGCTGAGCGAGGCGGCGCAGAGCCGGGTCGTGGACATCCAGGCGATGCGCGAGGACATCAGCCTGCCGGACGAGGACGTGCCCAAGTACATGCTGCACATCAAGCGCAGCGCGGCGTTCAATCCGCAAGCCTGGGCGAACTACCGGACCCAGCGGCAGACCGACTTCCAGTCACTGCCGACGTACCTGTCGGCGGACGTCATGGAGGACACCCGGCGGATGATCCGCAACCTCCAGGCGACCGGCATCGAGGAGGTGGCGGTCGTGGACCTGTCCCCCAAGTGGCTTCCGGTCTCGGTGGTCCGGGTCGTCGTGCCCGGCATCGAGTCGTGGGCGATCGACCGAGGCCGCCTCGGATTCCGTGCGGCCGCCGTGTGGGAGGAGAACCTGGGCCTCCTGCGGGACGCCCTCGCCGAGGCCGCGCACCGGCAGGAGGCACTGCGATGA	MKLRNSVPKVAGGGPHRERTTEETWRTIQPYLRRVGVTRVADITGLDRIGIPVYNAIVPKSSDLISVYNGKGASHLDAKTSAVMEAVERFAAWQPRTPDVVGSVDDLRRDGIRVVHPDSINIERFKQYRDHFPISWVMGTELISGEDIAVPQYLAGYYQSFHETPPFPICTTNGIASGNSVEEATCHALCELIERDDWTMAEVISNRLSRAVTKGTVAPGIPETVEQWFMERNRSIDQETLPAPHRRLIERYRAANLSVELKSIMSHNGIPSFLCVVSEDLGPTFSRSHQGLGTHPDRDVAALRALSEAAQSRVVDIQAMREDISLPDEDVPKYMLHIKRSAAFNPQAWANYRTQRQTDFQSLPTYLSADVMEDTRRMIRNLQATGIEEVAVVDLSPKWLPVSVVRVVVPGIESWAIDRGRLGFRAAAVWEENLGLLRDALAEAAHRQEALR	MPNDWIPTSHENCSLVPGPFYHGTKAKLAIGDLLSPGHPSHFEQGRRLKHIYFAALMEPAIWGAELAMSLSRQEGRGYIYIVEPLGPFEDDPNLTNKKFPGNPTKSYRTSESLRIVEVVEDWQGHSPDVLQGMLASLEDLQRRGLAIIED	301.33	gnl|BL_ORD_ID|694|hsp_num:0	736		
BGC0000625.1|Thioviridamide_16 # 15458 # 16114 # 1 # ID=1_16;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=10bp;gc_cont=0.670	BGC0000625.1|Thioviridamide_16 	15458	16114	+	Loose	500	25.0238	ADC-10	20.0	3003855	protein homolog model	n/a	n/a	cephalosporin	antibiotic inactivation	ADC beta-lactamase without carbapenemase activity	ATGAGGACCGTGATATTCGTCGGACCCAGTGTCGAGCGGGACGTCCTCGAACGGATCCTTCCCGACGCCGACTTCCGCCCGCCGATCGAGCGGGGCGACATCGACACCCTGCTCGCCGAGCCGGTGACACCCGACGCCATCGGAGTCGTCGACGGGAAGTTCCTGCACGCGATGTCGATCTCGCCGAAAGAGATCCTCAAGGCGCTCGCACGGGACGTCCGCGTGTTCGGATCATCGAGCATGGGCGCCCTGCGAGCTGCCGAACTCGATCTCTACGGCATGACCGGCGTGGGGAAGATCTACGCGTCGTACGCCAGTGGCGCCCTGGACGCGGACGACGAGGTGGCCATCACCTTCGACCCGGAGACCCTGCGCGCGCTGTGCGTTCCGATGGTGAACATCCGCACCTCGGTGGAGGAACTCGAGGAATCGGGCCGTATCACCGCCGCAGAGGCGAGCGACGTGCTGAACACGGCCAAGGGCATGTACTTCCCCGAGCGGAGTCACTCGAACATCCGTCTGGCGCTGCAGCGCGACGGATGGTCGCAGGAGCGGGCCACCGAGGTCCAGCGACTCCTGGACGGGTCGACCGACCAGAAGCGCGCGGACGCGATCGAACTCGCCCAGCGGCTGCGGGACCTGGCAGCCGCCTCATGA	MRTVIFVGPSVERDVLERILPDADFRPPIERGDIDTLLAEPVTPDAIGVVDGKFLHAMSISPKEILKALARDVRVFGSSSMGALRAAELDLYGMTGVGKIYASYASGALDADDEVAITFDPETLRALCVPMVNIRTSVEELEESGRITAAEASDVLNTAKGMYFPERSHSNIRLALQRDGWSQERATEVQRLLDGSTDQKRADAIELAQRLRDLAAAS	MRFKKISCLLLSPLFIFSTSIYAGNTPKDQEIKKLVDQNFKPLLERYDVPGMAVGVIQNNKKYEMYYGLQSVQDKKAVNSSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKELKNTPIDQVNLLQLATYTSGNLALQFPDEVQTDQQVLTFFKDWKPKNPIGEYRQYSNPSIGLFGKVVALSMNKPFDQVLEKTIFPALGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGPLDAPAYGVPAYGVKSTLPDMLSFIHANLNPQEYPADIQRAINETHQGFYQANTMYQALGWEEFSYPATLQTLLDSNSEQIVMKPNKVTAISKEPSVKMYHKTGSTNGFGTYVVFIPKENIGLVTLTNKRIPNEERIKAAYAVLNAIKK	56.19	gnl|BL_ORD_ID|2126|hsp_num:0	3314		
BGC0000625.1|Thioviridamide_17 # 16111 # 16953 # 1 # ID=1_17;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.718	BGC0000625.1|Thioviridamide_17 	16111	16953	+	Loose	800	25.0238	MuxA	24.74	3004073	protein homolog model	n/a	n/a	macrolide antibiotic; monobactam; tetracycline antibiotic; aminocoumarin antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGACGGCTGCGCGGAAGGGATTTCTGGAACGGGGATGGCGCCTGCCGGAACGGCGGCTGCCCGGCGGGACGGTCAGGGCGGTCCGGTACGCCGTCGTCAGCCACCTCGACGCGGCGGAACGGGCCGGCGGTGCGGCGCGGGCATGGGCGACGTTCCCCAAGCCGCACCTCGTCGTCCCCGCGATCGTGGAACTCGCCGACAGCCCCGAGATCACGGAATCGGTGGGTGACGTGCTCGGTGAAGCCTTCGGCATCTGGAGTTCCGCGATCTTCGTGTCGCCACCGGGCACCGGGACCGGCTTCGGCTGGCACCAGGACGCGCTCAGCTACGACCTCGACGGCGACGAGGGCCGGGCCCTGCGGGTCTGGGTCGCGCTGACGCCGGCCACCCCGGAGAACGGCACGATGTGGTTCGCCGACGGTTCGCACCGGTGCGGAACCCTCGACCACGACCTCGACGACCCGGTCCGAGGCCAGTCGGTGAGTCCGGACCGCGTACCCGGCGAGAAATTCCCGGTGGTGCTCGACGAGGGCGGGTTCAGCATGCACGACCTGCGTCTGGCGCACTCGTCGGGGCGGAACACGACGGACGGGCCAAGGATCAACGTGGCTCTGGACTACGTCGCTCCGGAGGCGGTGCCCGGAGCGGGCTGCGCCGGCGTACTGCCCCTGACCGCGGGCTTTCAGACCCCCTGGCGCGTGGAGCCCGACCCCCGGAAGGCAGCCGCGGCGCAGGCTCACGAGGCATGCGTCACCGAGTCCGCCCGGCGCCTTCGCAGTGCGATGGACCTTGCTGCCAGGGATGGTCTGCCCCTGGTGCTCGGGCCGGCTGATGACGCGTGA	MTAARKGFLERGWRLPERRLPGGTVRAVRYAVVSHLDAAERAGGAARAWATFPKPHLVVPAIVELADSPEITESVGDVLGEAFGIWSSAIFVSPPGTGTGFGWHQDALSYDLDGDEGRALRVWVALTPATPENGTMWFADGSHRCGTLDHDLDDPVRGQSVSPDRVPGEKFPVVLDEGGFSMHDLRLAHSSGRNTTDGPRINVALDYVAPEAVPGAGCAGVLPLTAGFQTPWRVEPDPRKAAAAQAHEACVTESARRLRSAMDLAARDGLPLVLGPADDA	MTPTTGKSKFRTLRPWLITALAFAAVIGLVMWLAAPASAPSSDGRPGRGGKPGAALPKANALTVGVARVEQGDLALHFNALGTVTAFNTVNVKPRVNGELVKVLFQEGQEVKAGDLLAVVDPRTYKAALAQAEGTLMQNQAQLKNAEIDLQRYKGLYAEDSIAKQTLDTQEAQVRQLQGTIRTNQGQVDDARLNLTFTEVRAPISGRLGLRQVDIGNLVTSGDTTPLVVITQVKPISVVFSLPQQQIGTVVEQMNGPGKLTVTALDRNQDKVLAEGTLTTLDNQIDTTTGTVKLKARFENADGKLFPNQFVNVRLLAQTLKGVLTIPANAVQRGTNGIYVYVVGADNKVSQRSVAIGTSENERVVVESGLKAGEQVVVEGTDRLRDGMEVRVAEASPQVLEGEPQKPQTGRPSGLQGDSVGSGSAE	65.73	gnl|BL_ORD_ID|2349|hsp_num:0	2717		
BGC0000625.1|Thioviridamide_18 # 16943 # 17620 # 1 # ID=1_18;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.692	BGC0000625.1|Thioviridamide_18 	16943	17620	+	Loose	275	23.8682	AAC(6')-Iaj	25.0	3003677	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	AAC(6')	ATGACGCGTGAGGAGATGACCGGCTCGATCGACCTTGGACGTGGGTTCGGTCCTGTCCATGACCAAGGGGCCGAACCCCTGTGCGCGCCGGCCGTGGTCGCCGGCATGCTGTGGGCTCGCGGCATCGTCGTATGCGTCCCCTGTCTGGGAGACATGGGCGCCCTCTCGGGGAACTCCGGGGGCGGCCGAACGGTCGCCTCGTGCCTCTCTGCCGTCGAGAGGTCGGGCGCGCCGCTGGCCGACGGGACGCCGGACCACTCGGCACACGGACGCGGAAGGGCCGTCCGTCTCCGCTGGACCGCCGCGGACGGCTCGGGATGGAGCGCGGGCGGAAAGCTCGACCACATCGAGTCCGCGCTGCGGGCCGGCCATCCGGTGGCGTTGCAGATCGGGCTGTACGGCAGTGCCGTCATGCGCAGTGGGACCGGCTGGCTGGGCACGCCGGAGCCCGACGAGGCCAGAGCTGGGCTGCACGCGGTCCTGTGTGTCGGAATCCTCCGCCATGGCCCGCGTTCGGGGCTGATCGTCAAGAATAGTTGGGGTACTGACTGGGGATCGGATGGTTATGGCATCGTTTCCATGGGCGTGCTGAGCTTGCCGGAGACCGGCAGGTTCGTCACGGTCACCGGCGCCCACGTAGCTCACGAACACCCCGTGGGTCCGAACAACTCGACATGA	MTREEMTGSIDLGRGFGPVHDQGAEPLCAPAVVAGMLWARGIVVCVPCLGDMGALSGNSGGGRTVASCLSAVERSGAPLADGTPDHSAHGRGRAVRLRWTAADGSGWSAGGKLDHIESALRAGHPVALQIGLYGSAVMRSGTGWLGTPEPDEARAGLHAVLCVGILRHGPRSGLIVKNSWGTDWGSDGYGIVSMGVLSLPETGRFVTVTGAHVAHEHPVGPNNST	MEYSIINIVEQNNYQIDAARILTNTFLDIGNKTWPTIQSAIDEVEECIDLPNICIGLIHNNQLIGWVGLRPMYDKTWELHPLVVRTDYQSKGIGSVLLAEVEKRAREVGIIGIILGTDDEYNKTSLSEITIDENNIFDAIQNIKNIHNHPYEFYQKNGYMIVGIIPNANGLRKPDIWMWKSLLN	122.28	gnl|BL_ORD_ID|2069|hsp_num:0	2191		
BGC0000625.1|Thioviridamide_19 # 17634 # 18482 # 1 # ID=1_19;partial=00;start_type=GTG;rbs_motif=AGG;rbs_spacer=6bp;gc_cont=0.678	BGC0000625.1|Thioviridamide_19 	17634	18482	+	Loose	1300	25.0238	vanTG	35.82	3002972	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; vanT	GTGACGTCTGGGAAGCGGGCTCGTGCCGCGCTTCGCTTCGTGACCCCGGCAGTCGTCCTGGCGAACGCGTTACTCGTGGTGACGGGAGTGTTCGACATCGGGCGTGCCGTACTCGTGGCGTTGGGGATGGAGGTGCTTCTCGCCGTCGTCACCGTGGTGTTGCTCGTGGCGGCGGGCACGACCTACCGCAGACGCCGGGAACTCGGCGACGGCCGCGGCCAAGCCCTCGCAGCCGCGGCGCAGGAGATTCTTCCGCCACCACTGTGGTCGCTGGCCCGGCACGAACTCGCCATTCTCAACGCACTGCTCCTGGTGCTTCGACGCAGGATCGACGCGCCCGACGGGGCTGCGACCTTCGGATACGGGAAGTCGCAGGCCCCGCTGTTCTACGGGCTGGCGGGCATCTCCCTGCTGGAGATCGTGTTGTTCGAGTGGCTGATCCCGTGGCCCTGGCTGAAGCTCACGATCGCGGTACTGTCGGTCTACGGCGCGGTCTGGGTGTTCGCCTTCTACCAGCTGATGCGGCGCAAACCGCACTACCTCACCGATCGGATGCTCGCGGTGCGGTGCGGGGCCATCGTCCGGCTCGACGTGCCGCTCGACGCGATCGACTCCGTCCGGAGCCAGATGGAGAACTGGGGCAACCGCTTCTACGAGGCCACCGACGACCAGGTCATCGCGATCAAGCCCGCCGGGTACACCAACGTGCGACTCCGGCTGAACCGTACGGTCGAGGCCGGGACCGGCCGGGGTCCGCTCAGCGGCACGTGTGTGTGCCTGGCCGCCGATGACCCGGACCTGCTGGTGTCGACCCTTCGCAAACAGCTGGTCGACCAGACAGCCGGCTGA	MTSGKRARAALRFVTPAVVLANALLVVTGVFDIGRAVLVALGMEVLLAVVTVVLLVAAGTTYRRRRELGDGRGQALAAAAQEILPPPLWSLARHELAILNALLLVLRRRIDAPDGAATFGYGKSQAPLFYGLAGISLLEIVLFEWLIPWPWLKLTIAVLSVYGAVWVFAFYQLMRRKPHYLTDRMLAVRCGAIVRLDVPLDAIDSVRSQMENWGNRFYEATDDQVIAIKPAGYTNVRLRLNRTVEAGTGRGPLSGTCVCLAADDPDLLVSTLRKQLVDQTAG	MTKNESYSGIDYFRFIAALLIVAIHTSPLSSFSETGNFIFTRIVARVAVPFFFMTSGFFLISRYTCNAEKLGAFIKKTTLIYGVAILLYIPINVYNGYFKMDNLLPNIIKDIVFDGTLYHLWYLPASIIGAAIAWYLVKKVHYRKAFLIASILYIIGLFGDSYYGIVKSVSCLNVFYNLIFQLTDYTRNGIFFAPIFFVLGGYISDSQNRLSLKRSIVGFIVCFALMFGEALTLHHFDIQKHDSMYVLLLPSVYCLFNLLLHFRGKRRTGLRTISLIIYIIHPFMIVVIRLFAKLLHLQSLLVENSLVHYIAVCFASVVLAVVITALLSSLKPKKAKHTADTDRAYLEINLNNLEHNVNTLQKAMSPKCELMAVVKAEAYGHGMYEVTTYLEQIGVSSFAVATIDEGIRLRKYGISSEILILGYTSPSRAKELCKYELTQTLIDYRYSLLLNKQGYDIKAHIKIDTGMHRLGFSTEDKDKILAAFSLKHIKVAGIFTHLCAADSLEENDVAFTNKQIGSFYKVLDWLKSSGLNIPKVHIQSSYGLLNYPELECDYIRVGVALYGVLSSTNDKTKLELDLRPVLSLKAKVVLIRKIKQGESVGYSRAFTATRDSLIAILPIGYADGFPRNLSCGNSYVLIGGRQAPIVGKICMDQLAVDVTDIPNVKTGSIATLIGKDGKEEITAPMVAESAESITNELLSRMGHRLNIIRRA	39.61	gnl|BL_ORD_ID|1468|hsp_num:0	1561		
BGC0000625.1|Thioviridamide_20 # 18561 # 19043 # -1 # ID=1_20;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.772	BGC0000625.1|Thioviridamide_20 	18561	19043	-	Loose	900	24.6386	MdtK	31.25	3001327	protein homolog model	n/a	n/a	fluoroquinolone antibiotic	antibiotic efflux	multidrug and toxic compound extrusion (MATE) transporter	ATGCCCGACGGCGCCGGCGTCCCGGCAGACGCCGCCCTCGGCATCGGCGCCCCGCTGAGCGGCCGCCCGCGCGAGGAGGTGCCGTTCCGGCCCGGACGCCTGCTGGCCGCCGTCACGATGCCCGCCCGTCCGGAGTCCGTTCCGGCGCTGCGCCGGCTGGCGCGGACGGTGGCGCGCAACCGCCGGCTGCCCGAGGAGGCCGAGGAGGCGCTCGGGGTGATCGTCACGGAGCTGGCCGCCAACGCCGTACTGCACAGCGGTGGTGCCGACGTCGCCCTGCTCCTGGAGATCGACGACACGGCGCTGACGGTGCGCGTGCGGGACAACGGTCAGTGGCGGGAGCGCCCCGCCCCCCGCTGCGAGCCCGCCGACCTGCACGCCGCGTTCGGCCGCGGCCTGACCCTCGTCGACGCGTACGCGGTCGACACCACACTCGAACGCACGGCCACCGGCACGGTGATGCGCGCGGTGGTCGCCCTGTGA	MPDGAGVPADAALGIGAPLSGRPREEVPFRPGRLLAAVTMPARPESVPALRRLARTVARNRRLPEEAEEALGVIVTELAANAVLHSGGADVALLLEIDDTALTVRVRDNGQWRERPAPRCEPADLHAAFGRGLTLVDAYAVDTTLERTATGTVMRAVVAL	MNVSTALRQAVVRTPWYAKRKSYKVLFWREITPLAIPIFLENTCVLLMGVLSTFLVSWLGKEAMAGVGLADSFNMVIMAFFAAIDLGTTVVVAFSLGKRDRRRARAAARQSLVIMTLFAVVLAVVIHYFGSEIINIVAGEATPEVKGLALTYLELTVLSYPAAAIALIGSGALRGAGNTKIPLMINGGMNILNIIISSILIYGAFSWQGLGFAGAGLGLTISRYIGAVAIIWVLMIGFNPALRIPLKSYLKPLNFGIIWEVMGIGIPASIESVLFNGSKLLTQMFVAGMGTNVIAGNFIAFSVAALINLPGNALGSASTIITGKRLGTGQIGQAERQLRHVFWMSTIVLTAIAWGTAPFAGLFASFYTQEQDVKEVVKVLLWLNAAFMPIWAAAWVLPSGFKGARDVRFAMWVSMLGMWGCRVVAGYTLGIVLGMGVVGVWLGMFLDWAVRGALFYWRLISGRWLWRYPRVKRE	33.76	gnl|BL_ORD_ID|1651|hsp_num:0	1752		
BGC0000625.1|Thioviridamide_22 # 22617 # 22901 # 1 # ID=1_22;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=7bp;gc_cont=0.751	BGC0000625.1|Thioviridamide_22 	22617	22901	+	Loose	750	23.0978	smeA	46.15	3003051	protein homolog model	n/a	n/a	aminoglycoside antibiotic; cephalosporin; cephamycin; penam	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGCTGCCGGTGTTGAAACTGCTGGAACACGAGGAGCGCGTCGCCCGCGAGCGGGTGGAGTCGCTGCGCGCGGAGGCCGACCGGGTCCTGGACGAACTGGCGCGCGCGGAGACGGACTGGGAGGGCTGGGCCGTCGCCCGGCAGCGGGTCAGGCAGGTCATGTCAGCGCCGGCCGAGGGGAAGACCGGCACCGGCGCCGCGGAGGCCGCGCTCACGGCCGCACGGCAGGAGACCGTCTCCGCGCACGAGCGCGTGCTGGACGCCAGAGCGTGGGCCGCCGACTGA	MLPVLKLLEHEERVARERVESLRAEADRVLDELARAETDWEGWAVARQRVRQVMSAPAEGKTGTGAAEAALTAARQETVSAHERVLDARAWAAD	MSLLRPLSRSPRPLLLPLLLALAACSADRTDAPAMPEVGVIIASAQPLALQQTLPGRAVPFEISEVRPQIGGLIRQRLFTEGQQVKAGQLLYQVDPAPYQAAFDTARGQLAQAEATVLSAQPKAERTRALVSMDAASKQDADDATSALKQAQANVIAARAALQAARINLDYTRVTAPIDGRIGTSSVTAGALVAAGQDTALTTIQRLDPVYLDVTQSSTQMLALRKRLDAGLVKAIDGKAQVKVLLEDGSTYAHEGTLEFVGSAVDPGTGNVKLRAVIPNPDGLLLPGMYLKAVLPMATDARALLVPQKAVVRNERGEPLLRLLDAKDHVVERRVSTGQVVGNQWQITSGLKAGERVIVSNGSAVSLGQQVKAVAPTTAQLAAMPAVDPNGNTDEKSH	23.62	gnl|BL_ORD_ID|1418|hsp_num:0	1507		
BGC0000625.1|Thioviridamide_23 # 23354 # 26623 # 1 # ID=1_23;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=7bp;gc_cont=0.761	BGC0000625.1|Thioviridamide_23 	23354	26623	+	Loose	1050	34.2686	YojI	28.36	3003952	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	ATGCGGCGGTGCGAGCTGCGGTTCGGGCTGCTGGGACCACCGGTCCTCTACGACCGGTACGACCCGGACGACACCGTCTCCGAGCAGCCGGTCCGCGTGATCGGCAGCCCCAAGGTCCGTGCGCTGCTGGCCGCGCTGCTCCTGGAGGCCGGCCGGGTGGTGTCGGTCGAGTCGCTCAAGGACGCCCTGTGGGGCGGCGCGCCGCCCGCCTCCGCGCAGGCGTCCCTGCACAACCACGTCACCCGGCTGCGCCGGCTCCTCGACGACCCCGAGCGGCTCAGGGCCGTCGCGCCGGGCTACCTGCTGCGCGTCAACGGCGGCGAGTTGGACGTGCACGTGTTCGACGCCCGCGTCGCCCAGGCACGCGCCGCGCACGCGCGGGGCGACTGGGAGCGGGTCGTGGAGACCTGCACCGCGGCGCTGACGCTGTGGCGCGGCACGCCCCTCAGCGGCGTCCCCGTCGGCGTCGGCGGCTACGCGCTGGTGCAGCGCCTGGAGGAGGCGCGGCTGCTCGCCCTGGAGTGGCGCTACGACGCCGAACTCGCCCTCGACGGCGACCGCTTGACCGCCCTGGCTCCGGAACTGGCGGCCCTGGTCGCCGAGCACCCGCTGCGCGAGGCGTACCACCGCCAGCTGATGCTCGCCCTCCACCGCACCGGCCGCCAGGCCGAGGCGCTCGCCGTCCACCGCGACCTGCGGGCCCGCCTCATCGACGAACTCGGCATCGAACCGGGCCCCCAGGTCCGCGACACCCACCTGCAGATCCTCCGCGACTCCCCGCCCCCGACGCCGGCGGCGGAGCCCCAGACAGCCTCAGGCACCCAACCGGCCGTCCCAACCGAAACAGCCCGAACCGAAGCAGCCCGAACCGAAGCAGCTCAGGCACCGCTGCCCCCACCCCCGGAACTCTCGCCGTCCACCGCATCCCGGCCCGCGCCGCCGGAAGGGACGCCGCACGCCACAGCACCACCCGAGGCCGCCGACGGTGCAGACCCCCCACAGGGGCCACCGGCACCCGACGACGAAACCCGCACGGGTGGTGCGGGTGGGAACCCCTATGCGGCCGAAGGCCGCCAAAGCCCGCACCCTCACCCACCCGCACCCGCACCCGCACCCGCCCAACTCCCCCCACCCCCAGCCCACTTCACCGGCCGGACCACCGAACTCACCGACCTCCACCACACCCTCACCGCCGAGCGCGGCGAACTCGCGGTGATCAGCGGGATGGCCGGCGTAGGCAAGAGCGCCCTCGCCCTGCACGCCGCCCACGCCCTGCGCGGACGGTTCCCCGACGGCCAGCTCTACGTCAATCTGCGGGGCGCGGCCCCGGGCATGACCCCCCTCGACGCCCCGCAGGCCCTCGCCGCCCTGCTCAGGGACCTCGGCGTGGACCCGCGCGGCATCCCCGAACACCCGGACGCGGCAACGGCGTTGCTCCGCTCCCTCCTCGCCCCCACCCGCACCCTCATGGTGCTGGACGACGCGGCCAACGCCGCCCAGGTACGGCCCCTGCTGCCGGCCGGCCCCGGCTGCGCCGTGATCGTCACCAGCCGCTCGCCGCTGACCGCCCTCGACGGCGCCCGGCGCTTCCCGCTCGGACCGCTGCCGGAGGAGGACAGCGCGGCTCTGCTACGCGCGGTGAGTGGACGCGACGGCCTCGACGCCTCGCACGCCCTCGTGGGGCTGACCGGCGGGCTGCCGCTCGCCCTGCGGGTCGTCGCCGCCCGCCTCGCGGCCCGCCGCGCGCTCACCCCGGACGTGCTCGCCGGCCAGCTCACCGCCACCGGCGGGCGCCTGCGGCACCTGGAGTACGACGACCTGAGCGTCCGCCGGTCCCTCGCCGTCGCACACGACGCGCTCGCCGCGAGCGAGCGGGAGACCGATCGGGACGCGGCCCGCGCCCTGCCCCGTATCGGCGCGCTCGACCTGCCGACGTACGGCGCCCCGCTGATCGCCCGCCTCACCGGCACCGACGAGCCCCGCGCCGAGGCCGCGCTGGACCGCCTCGTCGACGTGGCCCTGCTGGAGGAGACGGCGTACGGCCGCTACGTCCCCCACGGCCTGGTCCGCGACTTCGCACGCGAACTGGCCGGCGGCGACGGCCGCGCCCCGGACGGCACCCGTACCCCCGCCTGCCCCGACGCGGCCGCCCTCCGCTGGTACGCCGCCGTCACCGAACGCGTCCTCACCGCCGCCGTCGGACCCGGCCTCGACCGGGACGACCGGCTCCGCTCCACCGCCGCCCAGCCCGCGCGGCACGCGGCGGACGTGTCGGCCGTACCGTCCTTCGCGTCGGACCAGGAGGCCTTCGCCTGGGCCGACGGCGAACTGGAGAACATCGTCACCCTGGTCGCGCGGCACGCCGCCACCGCCGACGGGACCACCGCCGCTCACCTCTGCACCGTGGTCCGCCTCCTGTTCCCGTACGTACGGGGCAGCGGGCGGCTCGCGGAGATGGAGGTGCTCGGGCGGGCCGCGCTCAAGGCGGCGCGCCGGCTCGGGGACGCGGCGGCCGAGGCGTGCGCGCTCGTCGACCTCGCGGGCCTGCACTTCCTGACCGGCCGGCACAGCGAGGCCCTCGCCCTCAACGACGAGGCCCTGGACATCTGGCGGCGGCTCGGCACCGTCTCCTGGATCCGCCGCTGCCTGAACAACCGCGGACTGCTCCTGGACGGGCTCGGACGGCTCGCCGAGTCCGAGGACGCCCTGCGGCAGAGCCTGACCTACTCCCGGCAGCTGAACGACCCCTACGGCGAGGCGATCACCCACAGCCATCTCGGCAACCTCTTCGAGCACACCGACCCGCGCGCCGCCATCGAGCAGCACCGGCGGTCGCTGTCCATCGGGGAGACCATCGGCGCGGTCATCGTGCGGCACACGGCGCACTGCAACATCGGCTACGCCCACCTCACTCTCGGCGAACCGGCCGCCGCCGCCCGGCACTTCGAGCAGAGCCTGCGGATCCTCGGCGACCACGGTGACTGGCACGGCGAGTCGCAGACCCGGCTGGGCCTGGTGCGGGCGCTGCGGCTGCTGGGCGACCCCGTGCGTGCGGGCTGGGAGTGCGCCGAGCTGCTGCGCCGCGCGGACGACCGCGCCGACCGCTACGTCGGCGGTCTCGCCCGCCACCAGTCGGGTCTGCTGCTGCGCGACGAGGGACGCCACACGCAGGCGTACGACACCTGGCGCGCGGCCCTCGCGGCGCTCGACGGCACCGACGAGCAGACGGTGGCCGCCGAACTGCGGGAGCTGCTGGCCGAGGGGCCGTAG	MRRCELRFGLLGPPVLYDRYDPDDTVSEQPVRVIGSPKVRALLAALLLEAGRVVSVESLKDALWGGAPPASAQASLHNHVTRLRRLLDDPERLRAVAPGYLLRVNGGELDVHVFDARVAQARAAHARGDWERVVETCTAALTLWRGTPLSGVPVGVGGYALVQRLEEARLLALEWRYDAELALDGDRLTALAPELAALVAEHPLREAYHRQLMLALHRTGRQAEALAVHRDLRARLIDELGIEPGPQVRDTHLQILRDSPPPTPAAEPQTASGTQPAVPTETARTEAARTEAAQAPLPPPPELSPSTASRPAPPEGTPHATAPPEAADGADPPQGPPAPDDETRTGGAGGNPYAAEGRQSPHPHPPAPAPAPAQLPPPPAHFTGRTTELTDLHHTLTAERGELAVISGMAGVGKSALALHAAHALRGRFPDGQLYVNLRGAAPGMTPLDAPQALAALLRDLGVDPRGIPEHPDAATALLRSLLAPTRTLMVLDDAANAAQVRPLLPAGPGCAVIVTSRSPLTALDGARRFPLGPLPEEDSAALLRAVSGRDGLDASHALVGLTGGLPLALRVVAARLAARRALTPDVLAGQLTATGGRLRHLEYDDLSVRRSLAVAHDALAASERETDRDAARALPRIGALDLPTYGAPLIARLTGTDEPRAEAALDRLVDVALLEETAYGRYVPHGLVRDFARELAGGDGRAPDGTRTPACPDAAALRWYAAVTERVLTAAVGPGLDRDDRLRSTAAQPARHAADVSAVPSFASDQEAFAWADGELENIVTLVARHAATADGTTAAHLCTVVRLLFPYVRGSGRLAEMEVLGRAALKAARRLGDAAAEACALVDLAGLHFLTGRHSEALALNDEALDIWRRLGTVSWIRRCLNNRGLLLDGLGRLAESEDALRQSLTYSRQLNDPYGEAITHSHLGNLFEHTDPRAAIEQHRRSLSIGETIGAVIVRHTAHCNIGYAHLTLGEPAAAARHFEQSLRILGDHGDWHGESQTRLGLVRALRLLGDPVRAGWECAELLRRADDRADRYVGGLARHQSGLLLRDEGRHTQAYDTWRAALAALDGTDEQTVAAELRELLAEGP	MELLVLVWRQYRWPFISVMALSLASAALGIGLIAFINQRLIETADTSLLVLPEFLGLLLLLMAVTLGSQLALTTLGHHFVYRLRSEFIKRILDTHVERIEQLGSASLLAGLTSDVRNITIAFVRLPELVQGIILTIGSAAYLWMLSGKMLLVTAIWMAITIWGGFVLVARVYKHMATLRETEDKLYTDFQTVLEGRKELTLNRERAEYVFNNLYIPDAQEYRHHIIRADTFHLSAVNWSNIMMLGAIGLVFWMANSLGWADTNVAATYSLTLLFLRTPLLSAVGALPTLLTAQVAFNKLNKFALAPFKAEFPRPQAFPNWQTLELRNVTFAYQDNAFSVGPINLTIKRGELLFLIGGNGSGKSTLAMLLTGLYQPQSGEILLDGKPVSGEQPEDYRKLFSAVFTDVWLFDQLLGPEGKPANPQLVEKWLAQLKMAHKLELSNGRIVNLKLSKGQKKRVALLLALAEERDIILLDEWAADQDPHFRREFYQVLLPLMQEMGKTIFAISHDDHYFIHADRLLEMRNGQLSELTGEERDAASRDAVARTA	199.09	gnl|BL_ORD_ID|2264|hsp_num:0	2424		
BGC0000625.1|Thioviridamide_24 # 26660 # 28345 # -1 # ID=1_24;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.759	BGC0000625.1|Thioviridamide_24 	26660	28345	-	Loose	1850	27.7202	mdtF	35.71	3000796	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; penam	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGGCCGACCGCTGGGCACTCGCACCGGCCGAGGACGGAGGCGTGGACGTCGCCCCCCTCGGCCCGGACGGGCTGCCCGCCGGTCCGGTGCGGCGGGAGTCCGATCTCGCCGGGGCGGTGCGGAGCCGCCCGGAGGTGACGCGCTGGGTGTGGCGGTCCACCCCCGAGGTCTACCCGCGTCTGCTCGCCACGGGGGTGCGAGTGGAGCGGTGCTACGACATCGAGGACGTCGAGACACTCCTGCTGGGCCACGAGGGACGGTCCGGCGAGCCGCGCTCGGCCGCCGCCGCCCTGGCCCGCCTCCGCGGCGGCCCCGTACCTCCCGATCCGCGGCAGCGCGCGGCCGATCCGGGCGCCCAGTCCCCGCTGTTCGAGCCGCAGGGCGCCCCCCTGCCGCTCGACGACCTCCTCGCGGTCTACGCCGACCAGCAGCGGCGGCACGAGAAGGCCACCCACCCCGACCGGATGCGGCTGCTGACCGCCGCCGAGTCGGCGGGCATGCTCATCGCCGCCGAGATGAACCGGGCCGGCCTCCCCTGGAGCGCCGACGTCCACCGCGCCCTGCTGCACGACCTGCTCGGCGAGCGGTACGCGGGCGGCGGCGAACCCCGGCGCCTCGCCGACCTGGCGGACCAGGTGTCGGCCGCGTTCGGGCGCCGCGTCCGGCCCGACCTGCCCGCCGATGTGATCAAGGCGTTCGCACAGGCCGGCATCAAGGTGAGGTCGACGCGCCGCTGGGAGATCAGCGGAGTCGACCATCCGGCGGTCGAACCCCTGCTGGAGTACAAGAAGCTGTACCGGATCTGGGTGGCGCACGGCTGGTCCTGGCTGCACGACTGGGTGCGCGACGGCCGGTTCCGTCCGGAGTTCGTCGCCGGCGGCACGGTCACCGGGCGGTGGGTCACCAACGGCGGGGGCGCGCTGCAGATCCCCAAGGTGATCCGCCGGGCCGTGGTCGCCGACCCGGGCTGGCGGCTGGTCGTGGCCGACGCCGACCAGATGGAGCCCCGCGTGCTCGCCGCGATCTCCCGGGACCCCGGCCTCATGGAGGTGGCCGGCCGGGCGAGCGACCTGTACCAGTCCGTCTCCGACCGCGCGTTCTCCGGCGACCGGGACCAAGCCAAGATCGCCGTGCTCGGCGCGGTCTACGGCCAGACCTCCGGCGACGGCCTGAAGAACCTGGCCGCGCTCCGCCGCCGCTTCCCCCGCGCGGTGGCGTACGTCGACGAGGCCGCGCGGGCCGGCGAGGAGGGCCGGCTCGTGCGCACCTGGCTCGGCCGCACGTGCCCGCCGGTCGCCGGGGCGGACGAGGGCGCGGCGGAGGAGGCGGGCATCCCCGTCGGCGAGGACGACACCGACGGCCGCTCCTGGGCACCCGGCCACTCCTCCACCGACTCCCGCGCGCGGGGCCGCTTCGCGCGGAACTTCGTCGTCCAGGGCAGCGCCGCCGACTGGGCCCTGCTGATGCTCGCCGCGCTGCGCCGGTCCTGCGCGGGCCTTGCCGCCGAACTGGTCTTCTTCCAGCACGACGAGGTGATCGTGCACTGCCCCGCCGAGGAGGCCGACACCGTCGTCCGGGCCATCGGCGACGCCGCCGGTCTCGCCGGCCGGCTGACGTTCGGGGAGACACCGGTCCGGTTCCCGTTCACGACAGCGGTGGTGGAGTGCTATGCGGACGCCAAGTGA	MADRWALAPAEDGGVDVAPLGPDGLPAGPVRRESDLAGAVRSRPEVTRWVWRSTPEVYPRLLATGVRVERCYDIEDVETLLLGHEGRSGEPRSAAAALARLRGGPVPPDPRQRAADPGAQSPLFEPQGAPLPLDDLLAVYADQQRRHEKATHPDRMRLLTAAESAGMLIAAEMNRAGLPWSADVHRALLHDLLGERYAGGGEPRRLADLADQVSAAFGRRVRPDLPADVIKAFAQAGIKVRSTRRWEISGVDHPAVEPLLEYKKLYRIWVAHGWSWLHDWVRDGRFRPEFVAGGTVTGRWVTNGGGALQIPKVIRRAVVADPGWRLVVADADQMEPRVLAAISRDPGLMEVAGRASDLYQSVSDRAFSGDRDQAKIAVLGAVYGQTSGDGLKNLAALRRRFPRAVAYVDEAARAGEEGRLVRTWLGRTCPPVAGADEGAAEEAGIPVGEDDTDGRSWAPGHSSTDSRARGRFARNFVVQGSAADWALLMLAALRRSCAGLAAELVFFQHDEVIVHCPAEEADTVVRAIGDAAGLAGRLTFGETPVRFPFTTAVVECYADAK	MANYFIDRPVFAWVLAIIMMLAGGLAIMNLPVAQYPQIAPPTITVSATYPGADAQTVEDSVTQVIEQNMNGLDGLMYMSSTSDAAGNASITLTFETGTSPDIAQVQVQNKLQLAMPSLPEAVQQQGISVDKSSSNILMVAAFISDNGSLNQYDIADYVASNIKDPLSRTAGVGSVQLFGSEYAMRIWLDPQKLNKYNLVPSDVISQIKVQNNQISGGQLGGMPQAADQQLNASIIVQTRLQTPEEFGKILLKVQQDGSQVLLRDVARVELGAEDYSTVARYNGKPAAGIAIKLAAGANALDTSRAVKEELNRLSAYFPASLKTVYPYDTTPFIEISIQEVFKTLVEAIILVFLVMYLFLQNFRATIIPTIAVPVVILGTFAILSAVGFTINTLTMFGMVLAIGLLVDDAIVVVENVERVIAEDKLPPKEATHKSMGQIQRALVGIAVVLSAVFMPMAFMSGATGEIYRQFSITLISSMLLSVFVAMSLTPALCATILKAAPEGGHKPNALFARFNTLFEKSTQHYTDSTRSLLRCTGRYMVVYLLICAGMAVLFLRTPTSFLPEEDQGVFMTTAQLPSGATMVNTTKVLQQVTDYYLTKEKDNVQSVFTVGGFGFSGQGQNNGLAFISLKPWSERVGEENSVTAIIQRAMIALSSINKAVVFPFNLPAVAELGTASGFDMELLDNGNLGHEKLTQARNELLSLAAQSPNQVTGVRPNGLEDTPMFKVNVNAAKAEAMGVALSDINQTISTAFGSSYVNDFLNQGRVKKVYVQAGTPFRMLPDNINQWYVRNASGTMAPLSAYSSTEWTYGSPRLERYNGIPSMEILGEAAAGKSTGDAMKFMADLVAKLPAGVGYSWTGLSYQEALSSNQAPALYAISLVVVFLALAALYESWSIPFSVMLVVPLGVVGALLATDLRGLSNDVYFQVGLLTTIGLSAKNAILIVEFAVEMMQKEGKTPIEAIIEAARMRLRPILMTSLAFILGVLPLVISHGAGSGAQNAVGTGVMGGMFAATVLAIYFVPVFFVVVEHLFARFKKA	54.10	gnl|BL_ORD_ID|106|hsp_num:0	121		
BGC0000625.1|Thioviridamide_25 # 28553 # 29323 # -1 # ID=1_25;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.693	BGC0000625.1|Thioviridamide_25 	28553	29323	-	Loose	900	25.409	ANT(3'')-Ii-AAC(6')-IId fusion protein	31.18	3002598	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	AAC(6'); ANT(3'')	ATGGCGACCAATCCGAACATCACGGCATCCGTACGCCTCGACGACCTCATCGAGGCGATCAAGAAGGTTCACCCCGAACCCCTCGACCAGCTCCAGGACGCGGTGATCGCCGCCGATCACCTCGGTGACGTGGCCGACCACCTGATCGGGCACTTCGTGGACCAGGCCCGCCGCTCGGGCGCCTCCTGGACCGAGATCGGCAAGAGCATGGGCGTCACCCGGCAGGCGGCGCAGAAGCGGTTCGTGGCCAAGGAGTCGGCGGACCTCGACCCCAGCCAGGGCTTCAACCGCTACACCCCGCGCGCGCGGAACGTGGTCATGGCCGCGCACAACGAGGCGGTGGCCGCCCGCAACGCCGAGGGCCGCCCCGAGCACCTCGTCCTCGGCCTGCTGGCCGAACCGGAGGGCCTCGCCGCGAAGGCGATCGTCTCGCAGGGCGTTTTGCTGGACGCCGTACGCCAGGCGGCGACCGCCGCGCTTCCCCCGGCCGCGGACGACGTACCGGAACTCGTCCCGTACGGCCCCGACGCCAAGAAGGCCCTCGAACTCACCTTCCGCGAGGCCCTCCGCCTCGGCCACAACTACATCGGCACCGAGCACATCCTCCTGGCCCTCCTGGAACACGAGAACGGCCACGGCGTCCTCAATGACCTCGGGATCACCAAGCCCGCCACCGAGCAGTACGTCAACAGGGTCCTCGCCCTCCTCCTGGAACAGAAAAAGGCAGCGGGCGCGGCAGCGGAAGCGGCAACAGACACCCCGGAGTCCTGA	MATNPNITASVRLDDLIEAIKKVHPEPLDQLQDAVIAADHLGDVADHLIGHFVDQARRSGASWTEIGKSMGVTRQAAQKRFVAKESADLDPSQGFNRYTPRARNVVMAAHNEAVAARNAEGRPEHLVLGLLAEPEGLAAKAIVSQGVLLDAVRQAATAALPPAADDVPELVPYGPDAKKALELTFREALRLGHNYIGTEHILLALLEHENGHGVLNDLGITKPATEQYVNRVLALLLEQKKAAGAAAEAATDTPES	MSNAVPAEISVQLSLALNAIERHLESTLLAVHLYGSALDGGLKPYSDIDLLVTVAAQLDETVRQALVVDLLEISASPGQSEALRALEVTIVVHGDVVPWRYPARRELQFGEWQRKDILAGIFEPATTDVDLAILLTKVRQHSLALAGSAAEDFFNPVPEGDLFKALSDTLKLWNSQPDWEGDERNVVLTLSRIWYSAATGKIAPKDIVANWAIERLPDQHKPVLLEARQAYLGRGEDCLASRADQLAAFVHFVKHEATKLLGAMPVMSKTKLGITKYSIVTNSNDSVTLRLMTEHDLAMLYEWLNRSHIVEWWGGEEARPTLADVQEQYLPSVLAQESVTPYIAMLNGEPIGYAQSYVALGSGDGWWEEETDPGVRGIDQSLANASQLGKGLGTKLVRALVELLFNDPEVTKIQTDPSPSNLRAIRCYEKAGFERQGTVTTPDGPAVYMVQTRQAFERTRSDA	55.29	gnl|BL_ORD_ID|2045|hsp_num:0	339		
BGC0000625.1|Thioviridamide_26 # 29455 # 30576 # 1 # ID=1_26;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.760	BGC0000625.1|Thioviridamide_26 	29455	30576	+	Loose	960	26.5646	lsaC	24.05	3003112	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic; tetracycline antibiotic; oxazolidinone antibiotic; phenicol antibiotic; pleuromutilin antibiotic	antibiotic target protection	ABC-F ATP-binding cassette ribosomal protection protein	GTGACCAGTGAAGCCAGTACCGTCGAGCGGGCGTTTCGGGGCGCCCTCTACGACGACACCGACGCCGGACTCGACACGGGCGCCTCCCTGCTCGCCGCCGACCCCGGTGCCGACGCCGAACTCGCCCGGCGCGGCGAGGAGTTCATCGCGGCGGCCTGGCAGCGCGGCTGGCAGCCCGCCGACGTCGTCCGGCTGGTCCGGCGCGAACTGGACGAGACGCACGTGGTCCTGGCGGCCCGCCTCATCCGCGAGCAGGCCGGCGGGGACCGCCCGCGCGGGCACCGCTGGGCCGCCCAGCTCGACGCCCTCCCCGCCGCCCCCGCGCGCGGGACCGACCCGCGCGGCGGCGACCGCTTCTCGCACGCCACCGCCGTGCTGGAGCTGTACCGGCTGCTGCTGCGCCTGCCCGCCCTGGAACCCCTGGAGGAGCCGCGCCGCGAGCACGGCCCCACCGCCTCCCGCATGCTCACCCGCATCCGCGCGCTGCTCGCCAAGGCCGAGGCGACCGGCTACCCGGAGGAGGCGGAGGCCCTCAGCGCCAAGGCGCAGGAGCTGATGGCCCGGTACAGCGTCGACGAGGCGCTGCTCGCCGCCGGCGCCCCTTCCCCGGACGCGCCGGGAGCGTGCCGCATCGGGGTCGAGGCGCCGTACGAACAGGCCAAGGCGGTGCTGCTGGACGCGGTCGCCACCGCCAACCACTGCCGCGCGGTGTGGAACGAACCGCTCGGCTTCTCCACGGTGGTCGGCTTCGAGGCCGACCTGGAGGTGGTCGAGCTGCTCCACACCTCGCTGCTGGTGCAGGCCACGCACGCCATGACCAGGGCCGAGGCGGCCCAGCGAGCCGGTGGTCGCAGACGCACCAAGACCTTCCGGCAGTCGTTCCTCGCGGCCTACGCCCACCGGGTCGGCGACCGGCTCACGGCCGCCGCGGAGAGCCAGGTCACCCAGGACCTGCTGCCGGTGCTGGCCACGCGCGCGATAGCCGTCACCGACCGCACCGAGCGGATGTTCCCGCAGACCACGACGTCCCGGCTGCGCGGCGTGAGCGACGCGGCCGGCTGGACGGAGGGCGCACGGGCGGCGGACGAGGCCCAGGTCAGAGCCAGACCCCGGCTCGGCTGA	MTSEASTVERAFRGALYDDTDAGLDTGASLLAADPGADAELARRGEEFIAAAWQRGWQPADVVRLVRRELDETHVVLAARLIREQAGGDRPRGHRWAAQLDALPAAPARGTDPRGGDRFSHATAVLELYRLLLRLPALEPLEEPRREHGPTASRMLTRIRALLAKAEATGYPEEAEALSAKAQELMARYSVDEALLAAGAPSPDAPGACRIGVEAPYEQAKAVLLDAVATANHCRAVWNEPLGFSTVVGFEADLEVVELLHTSLLVQATHAMTRAEAAQRAGGRRRTKTFRQSFLAAYAHRVGDRLTAAAESQVTQDLLPVLATRAIAVTDRTERMFPQTTTSRLRGVSDAAGWTEGARAADEAQVRARPRLG	MSTIKIENLTFSYYGYVKPVFENVSFSFDTNWKTGLIGRNGIGKSTLFKLLLNQEVYKGKISKSVDFIKFPPNLSDTSKLGIELYRELISDEEEWKLFRELHLLKVDESLIYRKFETLSKGEQTKILLAILFTREDGFLLIDEPTNHLDMDGRKIVSEYLKNKKGFLLISHDRDFLDGCINHIISINRNSIDVQSGNFTSWYENKLMKDQFEISQNEKLRKDIKRLKEAARQSQIWSDKVENTKNGVKVSGVKPDKGHIGHQSAKMMKKSKNLENRQNKAIEEKQNLLKDIETKESLLLHPLHHHKNPLISVCDLSSYYGKKQILSNISFDIKQGDIVAIYGGNGSGKSTLIKILLGLNHEYSGDVKLASNLKISYVPQDTSNLTGSLNEYIHKQGVDETLCKTILRKLDFARELFEIDMKNYSDGQKKKVLIAVSLSKSAHIFIWDEPLNYLDVISRIQIEEIIKEANPTLIFVEHDKSFVEDIANKIIRL	75.81	gnl|BL_ORD_ID|1647|hsp_num:0	1748		
